Type 2 Diabetes

Health Condition

Type 2 Diabetes

  • Alpha-Lipoic Acid

    Taking alpha lipoic acid may improve insulin sensitivity and help protect against diabetic complications such as nerve damage.

    Dose:

    600 to 1,200 mg daily
    Alpha-Lipoic Acid
    ×
    Alpha lipoic acid is a powerful natural antioxidant that protects blood vessels and other tissues from free radical damage. Numerous clinical trials have been conducted to examine its effects in people with type 2 diabetes. The strongest evidence for its beneficial effects comes from trials in subjects with diabetes-related nerve complications (neuropathy).7,8 One placebo-controlled trial monitored 460 participants with type 1 or type 2 diabetes and mild to moderate polyneuropathy taking 600 mg per day of alpha lipoic acid or placebo for four years. Those taking alpha lipoic acid had significantly reduced symptoms and progression of neuropathy.9 In addition, clinical research suggests that alpha lipoic acid may improve insulin sensitivity, blood glucose control, and lipid metabolism, support weight loss, and reduce the impacts of diabetic complications such as retinopathy (damage to the retina in the eye), nephropathy (kidney dysfunction), and erectile dysfunction.10,11,12,13,14,15,16 Studies reporting benefits have generally used doses ranging from 600 to 1,200 mg of alpha lipoic acid per day.
  • Brewer’s Yeast

    Chromium-rich brewer’s yeast has been shown to be useful in treating type 2 diabetes in several ways, including by improving blood glucose control.

    Dose:

    9 grams (about 2 teaspoons) daily
    Brewer’s Yeast
    ×
    The first report on the blood glucose-lowering effects of brewer’s yeast emerged in 1958.17 Brewer’s yeast is a source of dietary chromium and low chromium levels have been associated with higher blood glucose, insulin, and inflammatory marker levels, as well as higher blood pressure and greater insulin resistance in people with type 2 diabetes.18 Preliminary and placebo-controlled research has indicated brewer’s yeast, in doses from 1.8–9 grams (providing up to 42 micrograms of chromium) per day may reduce blood glucose, triglyceride, and LDL-cholesterol levels, and increase HDL-cholesterol levels.19,20,17 One study compared brewer’s yeast providing 23.3 mcg of chromium per day to 200 mcg of chromium chloride per day in people with type 2 diabetes and found more favorable effects from the yeast, suggesting chromium in yeast may be more bioavailable.22 Taking chromium-enriched yeast supplements has also been found to improve glucose metabolism in subjects with type 2 diabetes.23 In a twelve-week trial, eating whole wheat bread made with chromium-enriched yeast was noted to improve glycemic control, body weight, and blood pressure compared to regular whole wheat bread in people with type 2 diabetes.24
  • Chromium

    Chromium has been shown to be useful in treating type 2 diabetes in several ways, including by improving blood glucose control.

    Dose:

    200 to 500 mcg daily, or more under doctor supervision
    Chromium
    ×

    Chromium status appears to be an important factor in glucose metabolism: individuals with lower chromium levels are more likely to have type 2 diabetes or pre-diabetes than those with higher levels, and low chromium status is associated with poor glycemic control and insulin resistance in people with type 2 diabetes.24,25,26,27 Furthermore, chromium supplementation has been shown to improve glucose control, insulin sensitivity, and other metabolic variables in people with insulin resistance and type 2 diabetes.

    In one placebo-controlled trial that included 64 participants with type 2 diabetes and heart disease, taking 200 mcg per day of chromium was associated with greater weight loss, lower fasting glucose and insulin levels, improved insulin sensitivity, and reduced blood pressure after four months. In addition, chromium supplementation led to lower levels of inflammatory markers and higher antioxidant capacity.28 A meta-analysis of 28 other randomized controlled trials concluded that chromium supplementation, particularly chromium chloride or chromium picolinate, reduces fasting blood glucose levels, triglyceride levels, and hemoglobin A1c values, and increases HDL-cholesterol levels.29 Because of its ability to help regulate dopamine and serotonin activity, some researchers propose chromium may be especially beneficial in people with type 2 diabetes who also suffer from depression or binge eating.30

    Studies showing beneficial effects from chromium supplementation have generally used 200 mcg per day or more. Many doctors recommend up to 1,000 mcg per day for people with diabetes.

  • Fenugreek

    Fenugreek seeds appears to lower blood glucose levels by slowing down carbohydrate digestion and absorption.

    Dose:

    5 grams or more daily
    Fenugreek
    ×
    Fenugreek seeds have a long history of use in the treatment of diabetes, and some fenugreek constituents have demonstrated anti-diabetes actions such as reducing starch digestion and glucose absorption in the gut, improving insulin sensitivity, and increasing insulin secretion.31,32 In clinical research, 60 subjects with type 2 diabetes who took 10 grams per day of hot water-soaked fenugreek seeds for six months had better blood glucose control than matched patients who received no fenugreek.33 Taking 10 grams per day of fenugreek seeds was reported to reduce the risk of type 2 diabetes in people with pre-diabetes in another controlled study.34 A placebo-controlled trial found 500 mg of fenugreek extract containing high amounts of constituents called furostanolic saponins improved blood glucose control and reduced medication need in people with type 2 diabetes after 90 days.35 A meta-analysis that included eight randomized controlled trials noted that, despite the overall low quality of the studies, fenugreek, in doses of at least 5 grams per day, appears to improve blood glucose control in people with type 2 diabetes, and the effects are greater with higher doses. Doses of up to 100 grams per day of fenugreek were used in the studies.36
  • Fiber

    Taking fiber supplements may improve blood glucose control and reduce insulin resistance in people with type 2 diabetes.

    Dose:

    15 grams (about 1 tablespoon) daily
    Fiber
    ×
    Studies have consistently shown that high intake of dietary fiber improves insulin resistance and lowers the risk of type 2 diabetes by 20–30%. This effect is mainly attributable to grain and cereal fibers, rather than fibers from fruits and vegetables, and may be due in large part to their positive impact on the gut microbiome.37,38,39 Meta-analyses of randomized controlled trials in people with type 2 diabetes have found that supplementing with approximately 13–15 grams of soluble fiber per day can improve blood glucose control and reduce insulin resistance.40,41 Psyllium, guar gum, oat bran, and inulin are examples of soluble fibers or soluble fiber sources that have been shown to be beneficial in type 2 diabetes.42,43,44,45
  • Folic Acid

    Folic acid supplementation may improve blood glucose control and insulin sensitivity in people with type 2 diabetes. Folic acid also lowers homocysteine levels and preliminary evidence suggests it may help to prevent and treat diabetes complications.

    Dose:

    6 mg methylfolate daily
    Folic Acid
    ×

    Folic acid, sometimes called vitamin B9, is needed along with vitamins B6 and B12 for healthy homocysteine metabolism. Elevated homocysteine levels have been associated with a range of chronic cardiovascular and neurological diseases.46 A meta-analysis pooled findings from 18 randomized controlled trials with a combined total of over 21,000 participants with type 2 diabetes. The analysis found folic acid supplementation lowered fasting blood glucose levels and reduced insulin resistance, but had no discernible effect on HbA1c, a marker of long-term blood glucose control.47

    Meta-analyses of studies have found high homocysteine levels are correlated with increased risk of diabetic retinopathy (damage to the visual center of the eye) and nephropathy (kidney damage).48,49 Because folic acid supplementation can lower high homocysteine levels in people with type 2 diabetes, it may be protective.50 In a preliminary trial, a B vitamin supplement providing 6 mg of methylfolate (the active form of folic acid), along with 70 mg of pyridoxal 5-phosphate (active vitamin B6) and 4 mg of methylcobalamin (active vitamin B12), per day improved retinal function and reduced retinal edema in participants with type 2 diabetes-related retinopathy.51 Several preliminary and placebo-controlled trials using the same B vitamin supplement indicate this combination may reduce symptoms of neuropathy related to type 2 diabetes.52,53,54

  • Glucomannan

    Glucomannan delays stomach emptying, leading to more gradual glucose absorption and lower blood glucose levels after meals.

    Dose:

    1 to 10 grams daily
    Glucomannan
    ×
    Glucomannan is a water-soluble dietary fiber derived from konjac root (Amorphophallus konjac) that delays stomach emptying, leading to a more gradual carbohydrate digestion and glucose absorption. Supplementing with glucomannan before eating has been shown reduce the post-meal elevation of blood glucose levels and long-term supplementation is associated with better blood glucose control and improvements in LDL-cholesterol levels in people with type 2 diabetes.55,56,57 Research in animals suggests glucomannan may be helpful in managing diabetes-related kidney dysfunction.58 Doses between 1 and 10 grams of glucomannan per day have demonstrated efficacy in clinical research.
  • Magnesium

    People with type 2 diabetes tend to have low magnesium levels. Supplementing with magnesium may improve glucose metabolism and help prevent diabetes-related cardiovascular disease.

    Dose:

    200 to 600 mg of elemental magnesium daily
    Magnesium
    ×

    Numerous studies have shown that poor magnesium status is associated with insulin resistance and type 2 diabetes.59,60,61,62 Furthermore, diabetes itself causes increased magnesium loss, resulting in a vicious cycle of dropping magnesium levels and worsening insulin resistance.63,64 Low magnesium levels have also been correlated with poor blood glucose control and increased risk of complications such as heart disease, kidney disease, and nerve damage in those with type 2 diabetes.65,66,67,68,69 Moreover, meta-analyses of randomized controlled trials have concluded that magnesium supplementation can lower blood pressure and decrease the risk of diabetes-related cardiovascular disease in people with type 2 diabetes.70,71

    Taking 250 mg of elemental magnesium (from magnesium oxide, gluconate, and lactate) per day for three months improved glycemic control and insulin sensitivity in a randomized controlled trial with 42 participants with type 2 diabetes.72 In a placebo-controlled trial, patients with diabetes-related kidney failure taking 250 mg of elemental magnesium (from magnesium oxide) per day for 24 weeks had improved vascular health, as well as reduced insulin, total cholesterol, LDL-cholesterol, and C-reactive protein levels, Hgb1c values, and insulin resistance scores, and increased antioxidant capacity.73 However, another placebo-controlled trial that included people with type 2 diabetes and related kidney disease found the combination of 250 mg magnesium (from magnesium oxide) plus 47 mg calcium (from calcium carbonate) per day improved lipid profiles but had no effect on glucose control and worsened insulin resistance after 12 weeks.74 Many doctors recommend that people with diabetes supplement with 200 to 600 mg per day of elemental magnesium from a highly bioavailable magnesium salt without added calcium.

  • Probiotics

    Probiotics can improve blood glucose control, as well as cholesterol and triglyceride levels, in people with type 2 diabetes.

    Dose:

    7 billion CFU or more of a mix of probiotic strains daily
    Probiotics
    ×
    The gut microbiome is increasingly recognized as a key player in regulating immune and metabolic functions in the body, and a growing body of research suggests probiotics may be beneficial to people with type 2 diabetes. Multiple clinical trials, reviews, and meta-analyses have shown that probiotic supplements can have a positive impact on blood glucose control, cholesterol and triglyceride levels, and blood pressure in people with type 2 diabetes.75,76,77,78,79 One review reported the best evidence is for supplements with multiple strains, including Lactobacillus acidophilus,Lactobacillus bulgaricus,Streptococcus thermophilus, and Bifidobacterium lactis, taken in amounts of 7 billion or more colony forming units (CFU) for six to 12 weeks.80
  • Psyllium

    Supplementing with psyllium has been shown to be a safe and well-tolerated way for people with type 2 diabetes to improve control of blood glucose and cholesterol levels.

    Dose:

    5 grams (about 1 teaspoon) twice daily with meals
    Psyllium
    ×
    Supplementing with psyllium has been shown to be a safe and effective way to improve control of blood glucose and cholesterol. A large review and meta-analysis that included 35 randomized controlled trials found that long-term psyllium use, at a dose of 10.2 grams per day taken before meals, reduces fasting glucose an average of 37 mg/dL and HgbA1c an average of 0.97% in people with type 2 diabetes, with greater improvements seen in those with higher baseline fasting blood glucose levels.81
  • Aloe

    Aloe vera leaf gel may help lower blood glucose levels and hemoglobin-A1c, a marker of long-term glycemic control, in people with type 2 diabetes.

    Dose:

    100 to 300 mg daily
    Aloe
    ×
    Several randomized controlled trials and two meta-analyses have found that aloe vera can help lower blood glucose levels and HgbA1c, and may improve lipid levels, in people with type 2 diabetes. The variety in study protocols makes it difficult to identify a consistently effective dose. In one trial, taking 300 mg of aloe vera leaf gel twice per day was effective for improving glycemic control and lipid metabolism in people with medically treated type 2 diabetes; in another trial, both 100 and 200 mg per day of powdered aloe vera gel had beneficial effects.82,83
  • American Ginseng

    Supplementing with American ginseng may help improve blood glucose control and insulin sensitivity in people with type 2 diabetes.

    Dose:

    1 gram three times daily
    American Ginseng
    ×
    Numerous clinical trials indicate American ginseng (Panax quinquefolius) may improve insulin sensitivity and glucose metabolism.84,85,86 Results from a placebo-controlled crossover study show a beneficial effect of 3 grams of American ginseng extract per day in participants with type 2 diabetes: eight weeks of treatment resulted in reductions in HgbA1c, fasting blood glucose levels, blood pressures, and LDL-cholesterol levels compared to placebo.87 In a twelve-week placebo-controlled trial that included 64 participants with type 2 diabetes and related high blood pressure, 3 grams of American ginseng per day resulted in decreased blood vessel stiffness and lower blood pressure.88 A typical dose used in clinical trials and found to be safe in those with type 2 diabetes is 1 gram three times daily.89 Some American ginseng extracts are standardized for their ginsenoside content.
  • Asian Ginseng

    Asian ginseng may help restore healthy insulin sensitivity and improve blood glucose and lipid levels in people with type 2 diabetes.

    Dose:

    5 grams of powdered root or an equivalent dose of Asian ginseng extract daily
    Asian Ginseng
    ×
    Asian ginseng is commonly used in Traditional Chinese Medicine to treat diabetes. Asian ginseng extracts and constituents known as ginsenosides have demonstrated antidiabetic effects such as lowering glucose levels, improving insulin levels, reducing insulin resistance scores, and improving lipid levels in multiple clinical trials and laboratory studies.90,91,92,93,94 In one placebo-controlled trial, taking 5 grams of Asian ginseng per day for 12 weeks led to better blood glucose response to glucose ingestion in participants with type 2 diabetes.95 A placebo-controlled trial using various doses of a vinegar extract of Asian ginseng noted 1.5 grams per day was associated with greater reduction in HgbA1c and fasting glucose levels than either 2 or 3 grams per day.96 Another trial found, in subjects with well controlled type 2 diabetes, 6 grams per day of crude Asian ginseng rootlets improved the response to a glucose load, lowered fasting insulin levels, and increased insulin sensitivity scores, but did not improve HgbA1c.97
  • Bilberry

    Bilberry may improve glucose metabolism and lower the risk of some diabetic complications, such as diabetic retinopathy.

    Dose:

    160 mg two to three times daily
    Bilberry
    ×
    Like other berries and darkly pigmented fruits and vegetables, bilberry (Vaccinium myrtillus) is rich in polyphenolic compounds called anthocyanins. Laboratory and animal studies suggest bilberry and anthocyanins can improve glucose metabolism and insulin sensitivity through multiple actions, including reducing inflammation and oxidative stress, inhibiting carbohydrate-digesting enzymes, and improving the gut microbiome.98,99,100 Eating a diet high in anthocyanins has been consistently found to be associated with lower risk of type 2 diabetes, and clinical evidence shows anthocyanins from bilberry or other berries, especially when taken with meals, can improve blood glucose control and insulin sensitivity in people with type 2 diabetes. In one study, a single 470 mg dose of standardized bilberry extract (36% anthocyanins) before eating reduced the post-meal increase in blood glucose in subjects with type 2 diabetes.101,102,103,104,105,106,107 Bilberry and anthocyanins may also help to prevent and treat some diabetic complications. For example, a growing body of evidence suggests bilberry and anthocyanins can improve microvascular health and retinal function in people with diabetic retinopathy.108
  • Biotin

    Biotin may improve glucose and triglyceride levels in people with type 2 diabetes and reduce pain from diabetic nerve damage.

    Dose:

    9 to 15 mg daily
    Biotin
    ×

    Biotin is a B vitamin needed to activate a major enzyme involved in glucose metabolism. In a clinical trial, 43 participants with type 2 diabetes were found to have lower serum biotin levels compared to healthy people without diabetes. Supplementation with 3 mg of biotin three times per day (along with a probiotic) for two months led to normalization of glucose levels. In addition, five participants who continued to take biotin for four years maintained these benefits.109 In another trial, taking 64.1 micromoles (15 mg) of biotin per day for 28 days led to reductions in high triglyceride levels, but had no effect on glucose or insulin levels in people with type 2 diabetes.110 Case reports suggest long-term treatment with high-dose biotin may reduce symptoms of diabetes-related nerve pain.111

    It is thought that biotin may have a synergistic effect with chromium. Placebo-controlled trials investigating the effects of taking 600 micrograms of chromium (as chromium picolinate) plus 2 mg of biotin per day have found this combination improves blood glucose control and triglyceride and other lipid levels; however, it is worth noting these trials were funded by the manufacturer of the chromium/biotin supplement they used.112,113,114,115

  • Bitter Melon

    Bitter melon may help lower blood glucose levels and improve overall metabolism in people with type 2 diabetes.

    Dose:

    2 grams daily
    Bitter Melon
    ×
    Bitter melon (Momordica charantia) is a common vegetable in parts of Asia and has been used historically to treat diabetes. Constituents from bitter melon were shown to have anti-inflammatory activity and the ability to inhibit enzymes needed for carbohydrate breakdown and glucose absorption in the gut.116 Two meta-analyses that each included four trials found bitter melon had no significant effects on HgbA1c or blood glucose levels.117,118 A more recent meta-analysis that included ten trials found positive effects on glycemic control, but noted the evidence was primarily from low-quality studies.119 One placebo-controlled trial with 24 participants with type 2 diabetes found taking 2,000 mg of bitter melon per day for three months resulted in reductions in weight, body fat, waist circumference, and HgbA1c, and improved blood glucose control and insulin secretion in response to glucose.120 A ten-week trial with 95 participants with type 2 diabetes compared bitter melon extract (2,000 mg per day) to the anti-diabetes drug glyburide (DiaBeta®, 5 mg per day); bitter melon was more effective at lowering cardiac risk but not as effective at lowering blood glucose levels.121
  • Cinnamon

    Cinnamon may improve glucose levels in people with type 2 diabetes.

    Dose:

    1 to 3 grams daily
    Cinnamon
    ×
    A number of randomized controlled trials have found adding 1 to 3 grams of cinnamon per day to usual treatment for two to three months can improve blood glucose control and lower HgbA1c in people with type 2 diabetes.122,123,124,125,126,127 However, not all studies have reported positive effects.128 Two meta-analysis of randomized controlled trials concluded that, although the evidence was difficult to analyze due to differences in study methods, cinnamon appears to lower blood glucose levels, but not HgbA1c, in people with type 2 diabetes.129,130
  • Coenzyme Q10

    Supplementing with CoQ10 may improve blood glucose control, insulin sensitivity, and cardiovascular health.

    Dose:

    100 to 200 mg daily
    Coenzyme Q10
    ×
    Coenzyme Q10 (CoQ10) is an antioxidant that plays an important role in cellular energy production. People with type 2 diabetes have been found to have significantly lower blood levels of CoQ10 compared with healthy people. In multiple clinical trials, CoQ10 supplementation has been shown to lower blood glucose levels and HgbA1c, improve insulin sensitivity, and raise antioxidant status.131,132,133,134,135 Meta-analyses of randomized controlled trials have concluded that CoQ10 supplementation can improve blood glucose levels, HgbA1c, and cardiovascular risk factors in people with type 2 diabetes.136,137 Although it has been suggested that CoQ10 might help reduce diabetes complications through its antioxidant effects, one clinical trial found no benefit of CoQ10 in treatment of diabetes-related neuropathy.138 Doses of CoQ10 used in the research are 100–200 mg of CoQ10 per day.
  • Crepe Myrtle

    Crepe myrtle has been used in folk medicine to treat diabetes, and preliminary research suggests it may lower blood glucose levels.

    Dose:

    32 or 48 mg of an herbal extract standardized to contain 1% corosolic acid
    Crepe Myrtle
    ×
    Lagerstroemia speciosa, commonly known as crepe myrtle or banaba, grows in various tropical countries and Australia and has a history of use as a treatment for diabetes. Laboratory and preliminary clinical research suggests crepe myrtle and its active constituent corosolic acid may quickly lower blood glucose levels, inhibit carbohydrate breakdown and glucose absorption, and improve glucose and lipid metabolism.139 In a preliminary study that included people with type 2 diabetes, two weeks of treatment with 32 or 48 mg of a crepe myrtle extract standardized to contain 1% corosolic acid resulted in a fall in blood glucose levels averaging 20–30%, with a slightly better effect seen with the higher dose.140 Although these results are promising, additional studies are needed to demonstrate the long-term safety and efficacy of this herbal preparation.
  • Green Tea

    Green tea may protect cardiovascular health and improve metabolism.

    Dose:

    The best effective dose is unknown, but doses providing 450 mg of total green tea polyphenols (catechins) daily are considered moderate; doses providing 800 mg of EGCG or more daily have been linked to liver injury and are not considered safe.
    Green Tea
    ×
    Green tea is a rich source of antioxidant polyphenols called catechins, including the well-studied epigallocatechin gallate (EGCG). Through their anti-inflammatory and antioxidant effects, green tea catechins appear to protect cardiovascular health and improve metabolism in obesity, insulin resistance, and type 2 diabetes.141,142,143 Green tea consumption has been correlated with lower risk of type 2 diabetes and diabetes-related heart disease.144 In a preliminary trial, 400 mg per day of green tea extract standardized to contain 90% green tea polyphenols and 45% EGCG reduced arterial stiffness in subjects with type 2 diabetes.145 Although a meta-analysis of 17 randomized controlled trials, including a total of 1,133 subjects with various metabolic disorders, found that green tea consumption significantly improves blood glucose control and insulin sensitivity, another meta-analysis of six studies that only included participants with type 2 diabetes or pre-diabetes found no beneficial effects of green tea or green tea extract on insulin resistance or measures of glycemic control.146,147 Although an effective dose has not been identified, doses providing 800 mg of EGCG or more per day have been linked to liver injury and are not considered safe.148
  • Gymnema

    Gymnema may stimulate the pancreas to produce insulin and help normalize blood glucose control in people with type 2 diabetes.

    Dose:

    400 to 1,000 mg daily
    Gymnema
    ×
    Gymnema has a long history of traditional use treating diabetes, and studies suggest gymnema and its active component, gymnemic acid, have anti-diabetes effects including reducing glucose absorption, stimulating the pancreas to produce insulin, and lowering triglyceride accumulation.149 So far, no double-blind trials have confirmed the efficacy of gymnema to treat diabetes. However, in preliminary studies, doses of 400 mg, 500 mg, and 1 gram per day of gymnema extract have been found to reduce blood glucose levels, increase insulin production, and improve markers of glycemic control in people with type 2 diabetes, in some cases allowing study participants to reduce their use of diabetes medications.150,151,152,153 Gymnema is not a substitute for insulin therapy, but insulin doses may need to be lowered while taking gymnema to avoid hypoglycemia.
  • Hairy Basil

    Taking hairy basil seeds may help lower blood glucose levels in people with type 2 diabetes.

    Dose:

    10 grams three times daily with meals
    Hairy Basil
    ×
    Extracts from the leaf and seed of hairy basil (Ocimum canum), also known as Thai basil, have been found to reduce blood glucose, free radical, and cholesterol levels and increase the insulin response to glucose in animal models of type 2 diabetes.154,155,156 Long-term supplementation with 30 grams per day of hairy basil seeds improved glucose metabolism in a preliminary clinical trial in people with diabetes, and the study’s authors attributed the effect to the increase in dietary fiber.157
  • Holy Basil

    Taking holy basil may help people with type 2 diabetes control their blood glucose levels.

    Dose:

    1,000 to 2,500 mg daily
    Holy Basil
    ×
    Holy basil (Ocimim sanctum), also known as tulsi basil, has demonstrated positive effects in multiple studies using animal models of type 2 diabetes.158,159,160,161 A randomized controlled trial in people with type 2 diabetes found 2,500 mg of holy basil per day lowered blood glucose and cholesterol levels.162 Another pilot trial in overweight and obese youth found holy basil, at 500 mg per day for eight weeks improved glucose, insulin, triglyceride, and cholesterol levels, as well as markers of insulin resistance.163
  • L-Carnitine

    Supplementing with L-carnitine may reduce glucose, cholesterol, and triglyceride levels, and support medical therapies for type 2 diabetes.

    Dose:

    2 to 4 grams daily
    L-Carnitine
    ×
    L-carnitine is an amino acid needed to properly utilize fat for energy. By supporting healthy fat metabolism, L-carnitine plays an important role in preserving normal insulin sensitivity and glycemic control.164,165 People with type 2 diabetes have been found to have lower levels of circulating L-carnitine than healthy people, and in people with type 2 diabetes, lower blood L-carnitine levels are correlated with higher blood glucose and triglyceride levels, lower free radical-quenching capacity, and greater risk of diabetes complications.166,167 Supplementing with L-carnitine has been shown in multiple human and animal studies to improve glucose tolerance and lipid metabolism in the context of insulin resistance.168 A meta-analysis of randomized controlled trials concluded 2–4 grams of L-carnitine per day can effectively reduce fasting blood glucose, total cholesterol, and LDL-cholesterol levels.169 Clinical trials further show the potential for 2–4 grams of L-carnitine per day to augment other therapies for improving metabolism in people with diabetes, including glimepiride, orlistat, sibutramine, simvastatin, and a low-calorie diet.170,171,172,173,174 In addition, a placebo-controlled trial found 600 mg per day of L-carnitine alleviated diabetes-related muscle cramps (a form of diabetic neuropathy) in people with type 2 diabetes.175
  • Milk Thistle

    Supplementing with milk thistle extract may improve blood glucose levels, HbA1c, and insulin sensitivity, and reduce oxidative stress and inflammation.

    Dose:

    140 mg of silymarin three times daily
    Milk Thistle
    ×
    An extract of milk thistle (Silybum marianum) called silymarin, at a dose of 140 mg three times per day, has been shown in placebo-controlled research to improve blood glucose, insulin, and triglyceride levels, and reduce HbA1c and markers of insulin resistance, oxidative stress and systemic inflammation in people with type 2 diabetes.176,177,178 In addition, preliminary research indicates a combination supplement containing silymarin and berberine (a compound found in several medicinal plants including goldenseal [Hydrastis canadensis]) may improve glycemic control and lipid metabolism in people with type 2 diabetes.179,180
  • Onion

    Onion may lower blood glucose levels and improve glucose tolerance in people with type 2 diabetes.

    Dose:

    2 to 3.5 ounces fresh onion daily
    Onion
    ×
    Onions have been used traditionally to treat diabetes. Animal studies suggest onion extracts may help reduce high blood glucose levels.181 Onion and its constituents have been shown in the laboratory to inhibit enzymes involved in the breakdown and digestion of starches and other carbohydrates, as well as enzymes involved in glucose metabolism.182,183 Onion has further been found to stimulate insulin responsiveness and glucose uptake by cells.184 Preliminary trials have found eating onions, in amounts of 60 and 100 grams (about 2 and 3.5 ounces) per day, lowered fasting blood glucose levels and the fasting response to glucose ingestion (glucose tolerance) in subjects with type 2 diabetes.185,186
  • Pine Bark Extract (Pycnogenol)

    Pycnogenol may improve blood glucose control and help prevent diabetes complications such as retinopathy in people with type 2 diabetes.

    Dose:

    100 to 200 mg daily
    Pine Bark Extract (Pycnogenol)
    ×

    Preliminary research has suggested that pycnogenol may help lower blood glucose levels in people with type 2 diabetes.187 In a placebo-controlled trial with 48 subjects with type 2 diabetes, 125 mg of pycnogenol per day for 12 weeks led to reductions in fasting blood glucose and LDL-cholesterol levels, as well as blood pressure and HbA1c.188 In another 12-week placebo-controlled trial with 77 subjects with type 2 diabetes, 100 mg per day of pycnogenol lowered blood glucose levels, but improvement in HbA1c was not statistically significant.189

    Pycnogenol has been shown to be helpful for improving small vessel health and restoring healthy blood flow in people with type 2 diabetes and related vascular symptoms.190 Clinical trials have also reported its benefits in treating microvascular complications of type 2 diabetes, such as diabetic retinopathy, skin ulcers, and neuropathy. The doses of pycnogenol used in these studies are 100 to 200 mg per day.191,192,193,194,195

  • Pinitol

    Pinitol may improve glucose metabolism in people with type 2 diabetes.

    Dose:

    400 mg three times daily
    Pinitol
    ×
    Pinitol, a molecule related to inositol and found in high concentrations in soybeans, is believed to enhance the action of insulin. Placebo-controlled trials in participants with type 2 diabetes have found 1,200 mg of pinitol per day for 12–13 weeks decreased fasting blood glucose levels, improved insulin sensitivity, and lowered HbA1c.196,197 In another study, a single 1,200 mg dose of pinitol taken one hour prior to eating effectively lowered post-meal glucose levels in people with type 2 diabetes.198
  • Vitamin B6

    People with type 2 diabetes, and especially those with diabetes complication, tend to have low levels of active vitamin B6, a nutrient needed for healthy metabolism.

    Dose:

    35 mg of pyridoxal 5-phosphate twice daily
    Vitamin B6
    ×
    Pyridoxal 5-phosphate (PLP), the active form of vitamin B6, is needed in the body for a wide array of metabolic processes. It also serves as an antioxidant and reduces formation of advanced glycation end-products (AGEs), which cause widespread damage to proteins and DNA.199 Laboratory and animal research suggests PLP inhibits enzymes involved in carbohydrate digestion and absorption, resulting in lower spikes in blood glucose levels after eating.200 Many people with diabetes have low blood levels of PLP, and levels are even lower in people with diabetes complications such as nerve damage (neuropathy) and kidney damage (nephropathy).201,202,203 In a preliminary trial, subjects with neuropathy due to type 2 diabetes were treated with 35 mg of PLP, along with 3 mg of methylfolate and 2 mg of methylcobalamin (B12), twice per day for four weeks, followed by the same regimen once per day for the rest of a full year. Nerve function was significantly improved after six months and further improved after one year of treatment.204 This same combination of B vitamins was found helpful in people with mild-to-moderate type 2 diabetes-related retinopathy after six months.205
  • Vitamin C

    Supplementing with vitamin C may lower blood glucose levels and protect cardiovascular health.

    Dose:

    500 mg one to two times daily
    Vitamin C
    ×

    Vitamin C, at a dose of 500 mg twice per day, was found to reduce fasting blood glucose levels, although not HbA1c, after four months in a placebo-controlled trial.206 A meta-analysis of other controlled trials found vitamin C supplementation can reduce blood glucose levels (but not HbA1c) in people with type 2 diabetes, and is especially effective in those who are older and those who have taken vitamin C for 30 days or more.207

    Through its anti-inflammatory and antioxidant effects, vitamin C has been shown to lower blood pressure and improve cardiovascular health in people with type 2 diabetes.208 In addition, like other antioxidants, vitamin C reduces formation of advanced glycation end-products (AGEs), which cause widespread damage to proteins and DNA.209 Antioxidants like vitamins C and E protect against damage to micro-vessels and therefore have the potential to help prevent type 2 diabetes complications such as retinopathy, nephropathy, and neuropathy.210,211 Furthermore, low vitamin C levels in blood and in the eye have been correlated with increased risk of retinopathy.212,213 In a pilot study, a combination supplement with vitamin C and other antioxidant vitamins, minerals, and plant extracts improved vision in subjects with type 2 diabetes and early stage retinopathy.214

    High-dose vitamin C supplementation has been reported to interfere with some devices for self-monitoring of blood glucose levels. This can raise the risk of overtreatment leading to hypoglycemia.215 Therefore it is important that people with type 2 diabetes who rely on self-monitoring glucose devices talk with their healthcare provider before starting a vitamin C supplement.

  • Vitamin D

    4,000 IU per day

    Dose:

    1,332 IU daily
    Vitamin D
    ×

    Vitamin D is now recognized as necessary for healthy immune function, regulation of inflammatory processes, insulin production, and cellular responsiveness to insulin.216,217 Vitamin D deficiency has been linked to high blood glucose levels, insulin resistance, type 2 diabetes, and diabetes complications.218,219 Numerous studies have examined the effect of vitamin D supplementation on blood glucose control in people with type 2 diabetes, and meta-analyses of randomized controlled trials have found evidence of benefits, particularly in those with vitamin D deficiency.220,221,222 One meta-analysis found a minimum dose of 4,000 IU of vitamin D per day is needed to improve blood glucose management and insulin sensitivity in people with type 2 diabetes.223

    Vitamin D is vital for both large and small blood vessel health, and deficiency has been associated with cardiovascular and microvascular diabetes complications. More research is needed to clearly establish a role for vitamin D supplementation in prevention and treatment of diabetes complications.224

  • Zinc

    People with type 2 diabetes, especially those being treated with anti-diabetes medications, tend to be zinc deficient. In those with zinc deficiency, supplementation may improve blood glucose regulation and reduce insulin resistance.

    Dose:

    15 to 25 mg of elemental zinc daily
    Zinc
    ×

    Zinc is important for normal pancreatic insulin production and release. Zinc deficiency is very common in people with type 2 diabetes and may be related to genetic susceptibility.225 In one study, zinc deficiency was present in 77% of subjects being treated with metformin (a widely used anti-diabetes drug) and 90% of subjects being treated with both metformin and glimepiride (another anti-diabetes drug).226 A growing body of evidence shows zinc supplementation may be helpful in preventing and treating type 2 diabetes, but only those with poor zinc status appear to benefit.227

    In a placebo-controlled trial that included 200 participants with prediabetes, average zinc levels were noted to be lower than normal and taking 20 mg of zinc per day for one year resulted in reduced blood glucose, cholesterol, and LDL-cholesterol levels, and improved the fasting response to glucose ingestion (glucose tolerance), measures of insulin resistance, and pancreatic cell function. Moreover, 25% of those in given placebo progressed to type 2 diabetes, while only 11% of those given zinc developed diabetes.228 Nevertheless, the relationship between zinc status and type 2 diabetes risk remains unclear, as some research has noted a correlation between higher blood zinc levels and increased diabetes risk.229

    A controlled trial in people with type 2 diabetes with urinary protein loss (a sign of diabetes-related kidney damage) found that adding 50 mg of zinc (as zinc sulphate) to their diabetes treatment for 12 weeks improved blood glucose and triglyceride levels and reduced urinary protein loss.230 Studies have also shown that supplementing with a combination of melatonin (10 mg per day) plus zinc (50 mg per day [as zinc acetate]), can improve blood glucose and lipid levels and reduce urinary protein loss in people with type 2 diabetes.231,232

    Many doctors recommend that people with type 2 diabetes and low zinc levels supplement with 15 to 25 mg of zinc per day to normalize zinc levels. Taking high doses of supplemental zinc long term increases the risk of copper deficiency. Most multivitamin-mineral supplements provide adequate copper to prevent deficiency.

  • Açaí

    Preliminary evidence suggests açai may have benefits in type 2 diabetes.

    Dose:

    100 grams (about 3 ounces) açai berry pulp or the equivalent daily
    Açaí
    ×
    Açai berry is reported to be a traditional remedy for diabetes. A pilot trial in ten overweight but otherwise healthy adults found taking 100 grams of açai pulp per day for one month led to decreases in fasting glucose and insulin levels as well as after-meal blood glucose, triglyceride, total cholesterol, and LDL-cholesterol levels.233 Positive metabolic and anti-diabetic effects have been demonstrated in animal models of type 2 diabetes.234,235 Clinical trials evaluating açai’s effect in people with type 2 diabetes are needed.
  • Amylase Inhibitors

    Amylase inhibitors from various medicinal herbs and plant foods may reduce the usual after-meal rise in blood glucose levels in people with diabetes.

    Dose:

    Varies depending on source
    Amylase Inhibitors
    ×
    Amylase inhibitors are substances that reduce the activity of amylase, the digestive enzyme required to break down dietary starches into absorbable glucose. Many plants and plant foods, including vegetables and legumes, contain amylase-inhibiting compounds that may be useful in preventing and treating type 2 diabetes.236,237,238 For example, adding beans to a serving of rice reduces the rise in blood glucose, an effect that may be due in part to the amylase-inhibiting action of beans.239 A review of clinical trials reported that taking 1,500 to 3,000 mg of an amylase-inhibiting extract from white beans (Phaseolus vulgaris) before meals has been shown in multiple studies to reduce post-meal blood glucose levels and may promote weight loss.240 However, this review and most of the studies it included were funded by the manufacturer of the bean extract. Its usefulness as a therapy for type 2 diabetes has not been tested.
  • Coffee

    Drinking either regular or decaffeinated coffee has been associated with reduced type 2 diabetes risk in several studies.

    Dose:

    Amount providing 400 to 450 mg chlorogenic acid daily
    Coffee
    ×
    Preliminary research has identified a correlation between drinking either regular or decaffeinated coffee and reduced risk of type 2 diabetes.241,242,243 Test tube studies suggest that chlorogenic acid, a primary constituent found in coffee and in unroasted green coffee extract, may inhibit glucose production by the liver, which could theoretically lead to lower blood glucose levels.244 An animal study found that green coffee extract also prevented the reduction in insulin sensitivity caused by a high-fat diet.245 A double-blind trial found that healthy people who drank a sweetened coffee beverage containing green coffee extract (providing 400 to 450 mg of chlorogenic acids) had lower blood glucose levels during the following two hours compared to when they drank the same coffee beverage without added green coffee extract.246 However, no trials in people with type 2 diabetes have been performed.
  • Evening Primrose Oil

    Preliminary research suggests evening primrose oil may be helpful for preventing and treating diabetic neuropathy.

    Dose:

    4 grams daily
    Evening Primrose Oil
    ×
    Evening primrose oil is a source of the anti-inflammatory omega-6 fatty acid gamma linolenic acid (GLA). Animal research suggests evening primrose oil and GLA may be helpful for preventing and treating diabetic neuropathy.247,248,249 Supplementing with 4 grams of evening primrose oil per day for six months was found in a double-blind trial to improve nerve function and to relieve pain symptoms of diabetic neuropathy.250 However, the principal investigator who conducted these clinical trials was subsequently found by the professional conduct committee of the General Medical Council (United Kingdom) to have falsified the results of the research.251 Therefore, it is not clear whether evening primrose oil or GLA is of any value for patients with diabetic neuropathy.
  • Fish Oil

    Supplementing with fish oil can reduce inflammation and may lower triglyceride and cholesterol levels in people with type 2 diabetes.

    Dose:

    6 grams (about 1.25 teaspoons) of fish oil, providing approximately 2,000 mg of combined EPA and DHA, daily
    Fish Oil
    ×
    Fish oil and its polyunsaturated omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have been widely studied for their potential metabolic benefits. Clinical trials have reported conflicting evidence, with some studies finding positive effects, some no effects, and some negative effects of fish oil consumption on markers of metabolic health in people with type 2 diabetes.252 Attempting to explain these inconsistencies, one analysis suggested omega-3 fatty acids may be more beneficial in women than men.253 Nevertheless, a large meta-analysis that pooled findings from 45 randomized controlled trials with a combined total of 2,674 participants with type 2 diabetes found an overall positive effect of omega-3 fatty acids from fish on levels of markers of systemic inflammation, triglycerides, total cholesterol, LDL-cholesterol, and VLDL-cholesterol levels, as well as a small but statistically significant positive effect on HbA1c.254 Another meta-analysis of 17 studies with a total of 672 participants found omega-3 fatty acids from fish could improve insulin sensitivity in people with metabolic disorders, including type 2 diabetes.255
  • Fructo-oligosaccharides

    Fructo-oligosaccharides improve metabolic healthy by supporting growth of beneficial bacteria in the gut. Supplementing with fructo-oligosaccharides may improve blood glucose and lipid levels.

    Dose:

    10 to 20 grams (about 2 to 4 teaspoons) daily
    Fructo-oligosaccharides
    ×
    The gut microbiome is now recognized as an important target for anti-diabetes therapies, with its ability to impact carbohydrate and fat metabolism and regulate inflammatory activity in the body.256 Prebiotic fibers like fructo-oligosaccharides promote the growth of gut bacterial colonies associated with healthy metabolic function. A review of 27 clinical trials investigating the effects of prebiotics in people with type 2 diabetes reported the majority (74%) of studies found beneficial results on metabolic and/or inflammatory markers, including blood glucose and lipid levels. The best evidence was for fructo-oligosaccharides, with fewer trials performed using other prebiotics.257 A meta-analysis that included six randomized controlled trials using prebiotics in people with type 2 diabetes found there was a significant positive effect on fasting blood glucose levels, HbA1c, and lipid profiles. Prebiotic supplements used in the research provided 10–20 grams of fructo-oligosaccharides per day.258
  • Ginkgo

    Ginkgo may improve the efficacy of commonly used anti-diabetes medications. It also appears to help prevent and treat type 2 diabetes-related complications.

    Dose:

    120 mg daily
    Ginkgo
    ×
    Ginkgo (Ginkgo biloba) extract was found in a placebo-controlled trial to enhance the HbA1c-lowering effect of the widely used anti-diabetes drug metformin, while not directly altering metabolism of the drug.259 In another placebo-controlled trial that included participants whose type 2 diabetes was not well controlled by metformin, adding 120 mg per day of ginkgo resulted in greater reductions in HbA1c and fasting blood glucose and insulin levels, as well as body-mass index (BMI), waist circumference, and abdominal fat, after 90 days.260 Clinical research has shown ginkgo extract can improve kidney function in people with type 2 diabetes and early signs of nephropathy (kidney damage), and strengthen retinal blood flow in those with diabetic retinopathy (damage to the visual center of the eye).261,262 Treatment with the combination of ginkgo leaf plus a traditional Chinese herbal remedy (Liuwei Dihuang Pills) reduced the risks of developing retinopathy or nephropathy in a placebo-controlled trial that included 140 people with type 2 diabetes who were monitored for three years.263 Findings from animal studies suggests ginkgo may also have protective effects on nerve tissue and may be helpful in preventing and treating type 2 diabetes-related neuropathy (nerve dysfunction).264,265
  • Goldenseal

    Preliminary research with berberine (an active compound in goldenseal) for two months lowered blood glucose levels in people with type 2 diabetes.

    Dose:

    1 gram daily of berberine for two months
    Goldenseal
    ×
    In a preliminary trial, supplementation with 1 gram per day of berberine (one of the active compounds in goldenseal) for two months significantly lowered blood glucose levels in patients with type 2 diabetes.266
  • Hibiscus

    Hibiscus is a traditional remedy for diabetes. Preliminary research suggests it may lower blood pressure and improve lipid levels in people with type 2 diabetes.

    Dose:

    One cup of hibiscus tea two to three times daily
    Hibiscus
    ×
    Hibiscus has a history of use in treating diabetes. Laboratory studies show hibiscus and some of its active constituents have anti-diabetic effects, including enhancing the metabolic response to insulin and inhibiting enzymes that facilitate carbohydrate digestion and glucose absorption.267,268,269,270 Its potential to improve glycemic control and reduce production of advanced glycation end-products (AGEs, damaged molecules that cause cell and tissue injury) has been demonstrated in animal models of type 2 diabetes.271 In humans, drinking hibiscus tea two to three times per day for one month was found to improve lipid levels and reduce high blood pressure in subjects with type 2 diabetes.272,273,274 Hibiscus tea is usually made by infusing 1 to 2 teaspoons (3 to 6 grams) of dried flower into 1 cup (250 ml) of hot water.
  • Inositol

    Inositol has been shown to improve glucose metabolism and insulin sensitivity in women with polycystic ovarian syndrome, and preliminary evidence suggests it may lower HbA1c in people with type 2 diabetes.

    Dose:

    500 to 2,000 mg daily
    Inositol
    ×
    Disturbances in inositol metabolism are thought to be an underlying factor in insulin resistance and type 2 diabetes.275 Animal studies suggest inositol may reduce glucose absorption in the digestive tract and have insulin-like effects, increasing glucose uptake and utilization by cells.276,277 A pilot trial examined the effects of adding inositol in people with type 2 diabetes with persistently high HbA1c despite medical treatment. A supplement providing two types of inositol (550 mg of myo-inositol and 13.8 mg of D-chiro inositol per day) was added to their treatment. After three months, fasting blood glucose levels and HbA1c had decreased significantly.278 Reviews of clinical research have shown that inositol can improve glucose metabolism and insulin sensitivity in women with polycystic ovarian syndrome (PCOS), a condition marked by hormonal imbalance and increased risk of insulin resistance, type 2 diabetes, and cardiovascular disease.279,280
  • Manganese

    Manganese is important as an antioxidant and metabolic regulator. Supplementation to prevent deficiency may be helpful for people with type 2 diabetes.

    Dose:

    1.8 to 2.6 mg daily
    Manganese
    ×
    Manganese is an important nutrient for the activation of antioxidant and metabolic enzyme systems. Both high and low manganese levels can contribute to increased oxidative stress and the development and progression of type 2 diabetes.281,282 Animal and laboratory research suggest manganese supplementation might improve insulin sensitivity and protect blood vessels from damage due to high glucose levels in people with type 2 diabetes.283,284 Although clinical trials are lacking, taking a multivitamin/mineral supplement to ensure adequate manganese intake is a reasonable precautionary measure for people with type 2 diabetes.
  • Medium-Chain Triglycerides

    Replacing other dietary fats with medium-chain triglycerides may lead to metabolic benefits in people with type 2 diabetes.

    Dose:

    1 to 3 tablespoons MCT oil daily
    Medium-Chain Triglycerides
    ×
    Medium-chain triglycerides (MCT) contain fatty acids that have six to twelve carbon units and are found mainly in coconut and palm oils. Studies in which people with type 2 diabetes replaced usual long-chain fatty acid sources with MCT oils indicate its potential benefits. In a pilot trial, getting 31% of per day calories from MCTs for five days led to reduced post-meal blood glucose levels and appeared to strengthen insulin sensitivity in people with type 2 diabetes.285 Other preliminary research noted 30 days of getting 18% of per day calories from MCTs led to slight improvement in post-meal blood glucose control but no other measurable changes in glucose metabolism.286 A controlled trial found moderately overweight people with type 2 diabetes who took 18 grams per day of MCTs for 90 days had decreased insulin resistance, greater weight loss, and more reduction in waist circumference than those who took long-chain triglycerides.287
  • Mistletoe

    Mistletoe extract has been shown to stimulate insulin release from pancreas cells, and it may reduce diabetes symptoms.

    Dose:

    Refer to label instructions
    Mistletoe
    ×
    Mistletoe plants have been used traditionally to treat diabetes. Alcohol extracts from various mistletoe plants, including Viscum and Plicosepalus species, have been shown to stimulate pancreatic insulin production and release and improve glucose metabolism in animal models of type 2 diabetes.288,289 One such study found a water extract of mistletoe was not as effective as the alcohol extract.290
  • Moringa

    Moringa has been used traditionally to treat diabetes.

    Dose:

    Refer to label instructions
    Moringa
    ×
    Moringa (Moringa oleifera) leaf extract has a history of traditional use in treating diabetes. Findings from animal studies lend support for its potential benefits and suggest its effects may be due in part to its ability to inhibit enzymes involved in carbohydrate digestion and glucose absorption.291,292,293,294 A study in healthy adults showed moringa leaf, at doses of 1 gram, 2 grams, and 4 grams, stimulated insulin release, with greater effect as dose increased.295 However, a pilot trial that included 32 participants with type 2 diabetes found 8 grams of moringa leaf per day had no effect on blood glucose control.296
  • Olive Leaf

    Preliminary research suggests olive leaf may improve glucose metabolism and have benefits for people with type 2 diabetes.

    Dose:

    500 mg of olive leaf extract or three cups of olive leaf tea daily
    Olive Leaf
    ×
    In a placebo-controlled trial, 79 subjects with type 2 diabetes received 500 mg per day of olive leaf extract or placebo. After 14 weeks, those who received the olive leaf extract had lower fasting blood insulin levels and HbA1c, but no difference in post-meal insulin levels was seen.297 The same researchers also reported finding olive leaf extract inhibited starch digestion and glucose absorption in animals with experimental diabetes. On the other hand, 100 mg per day of olive leaf extract, in combination with fenugreek and bergamot extracts, was no better than placebo at restoring healthy glucose metabolism in a trial with 100 participants with prediabetes.298 Another trial included people with prediabetes who received either olive leaf tea of a control tea three times per day for 12 weeks. Olive leaf tea reduced fasting blood glucose levels and improved lipid levels.299 In overweight men at risk for developing type 2 diabetes, a high-polyphenol olive leaf extract (providing 51.1 mg of oleuropein and 9.7 mg of hydroxytyrosol per day) improved insulin sensitivity and pancreatic function after 12 weeks.300 More research in subjects with type 2 diabetes is needed.
  • Quercetin

    Quercetin has been found to improve glucose metabolism and reduce complications in animal models of type 2 diabetes.

    Dose:

    Refer to label instructions
    Quercetin
    ×
    Quercetin, a flavonoid widely found in the plant world, has well established antioxidant and anti-inflammatory properties. Higher dietary intake of quercetin has been correlated with a lower risk of type 2 diabetes in one study.301 Animal and laboratory research suggests quercetin may have a role to play in improving metabolism in type 2 diabetes and protecting against diabetes complications.302,303,304 A topical quercetin preparation, which also contains vitamins C and D, was found in a human clinical trial to be effective for relieving symptoms of neuropathy related to type 2 diabetes.305
  • Reishi

    Reishi may have some beneficial action in people with diabetes.

    Dose:

    Refer to label instructions
    Reishi
    ×
    Multiple studies using experimental and animal models of type 2 diabetes have reported anti-diabetes effects of reishi mushroom (Ganoderma lucidum) and its constituents.306,307,308,309 However, in a placebo-controlled trial with 84 participants, 3 grams per day of reishi mushroom for 16 weeks had no effect on glycemic control or any metabolic markers in people with type 2 diabetes.310
  • Taurine

    Supplementing with taurine may affect insulin secretion and action and may help some people with type 2 diabetes.

    Dose:

    Refer to label instructions
    Taurine
    ×
    Taurine is an amino acid that affects glucose and lipid metabolism by acting as an antioxidant and participating in regulation of insulin secretion and action.311 Low taurine levels have been linked to type 2 diabetes and other metabolic disorders, and animal studies suggest taurine supplementation may protect against diabetes complications.312,313 Few studies of taurine supplementation in people with type 2 diabetes have been performed, and these have yielded mixed results; one clinical trial indicated the effects of taurine on metabolism may be determined partly by genetics.314
  • Vanadium

    Vanadyl sulfate, a form of vanadium, may improve glucose control in people with type 2 diabetes.

    Dose:

    Refer to label instructions
    Vanadium
    ×
    Clinical trials using the vanadium salt vanadyl sulfate, in doses of 100 mg to 150 mg per day, indicate it may improve glucose control and insulin sensitivity in people with type 2 diabetes.315,316,317,318 Over a six-week period, a small group of people with type 2 diabetes were given 75 mg, 150 mg, or 300 mg of vanadyl sulfate (about 25–100 mg elemental vanadium) per day.319 Only in the groups receiving 150 mg or 300 mg was glucose metabolism improved and fasting blood glucose levels and HbA1c decreased; however, these higher doses cause digestive disturbances and were associated with reductions in beneficial HDL-cholesterol levels. Other forms of vanadium, such as a vanadium-maltol complex, also appear to improve glycemic control and are being explored for their safety.320
  • Vitamin B3 (Niacin)

    Dietary niacin (vitamin B3) is important for healthy management of cholesterol and triglycerides; however, high dose supplementation with niacin could worsen glycemic control in people with type 2 diabetes.

    Dose:

    Less than 2 grams daily
    Vitamin B3 (Niacin)
    ×
    Vitamin B3 (niacin) is an important nutrient for regulating lipid metabolism and has well established positive effects on cholesterol and triglyceride levels. High dietary intake of niacin may protect against diabetes-related fatty liver.321 Unfortunately, the intake of therapeutic amounts of niacin, such as 2 to 3 grams per day, has been associated with an increased risk of type 2 diabetes and worsening of blood glucose control in people with diabetes.322 A microencapsulated niacin (but not niacinamide) product, however, was found in a pilot trial to improve insulin sensitivity in men with obesity, possibly by altering the gut microbiome.323 The potential benefits of microencapsulated niacin in type 2 diabetes remain to be investigated.
  • Yerba Mate

    Preliminary research suggests yerba mate (Ilex paraguariensis) tea may improve measures of blood glucose control in people with type 2 diabetes.

    Dose:

    Refer to label instructions
    Yerba Mate
    ×
    In a preliminary trial, consumption of mate (Ilex paraguariensis) tea in the amount of 330 ml (about 12 ounces) 3 times per day for 60 days improved measures of blood glucose control in patients with type 2 diabetes.324
What Are Star Ratings
×
Reliable and relatively consistent scientific data showing a substantial health benefit.
Contradictory, insufficient, or preliminary studies suggesting a health benefit or minimal health benefit.
For an herb, supported by traditional use but minimal or no scientific evidence. For a supplement, little scientific support.

Holistic Options

Acupuncture may be helpful in the management of diabetes, or complications associated with the disease. A meta-analysis that pooled the findings from 21 controlled studies with a combined total of almost 2,000 participants found acupuncture appeared to improve blood glucose levels and HbA1c.325 In a controlled clinical trial, overweight individuals with type 2 diabetes who received metformin (a commonly used anti-diabetes medication) plus electro-acupuncture therapy ten times over a three-week period had greater weight loss and improvement in insulin sensitivity than those who received metformin alone.326 Improvements in symptoms of diabetic neuropathy with acupuncture therapy have also been reported.327 In one study with 25 subjects with type 2 diabetes, ten weeks of once-weekly acupuncture therapy resulted in reductions in most neuropathy symptoms, including burning pain, aching pain, prickling sensation, numbness, and pain from light touch.328

References

1. Gebel E. The Other Diabetes, LADA, or type 1.5. Diabetes Forecast 2010 May [cited 2015 Mar 14]. Available from URL: http://www.diabetesforecast.org/2010/may/the-other-diabetes-lada-or-type-1-5.html.

2. Hoogeveen EK, Kostense PJ, Jakobs C, et al. Hyperhomocysteinemia increases risk of death, especially in type 2 diabetes : 5-year follow-up of the Hoorn Study. Circulation 2000;101:1506-11.

3. 2015 Position Statement on Classification and Diagnosis of Diabetes. American Diabetes Association [cited 2015 Feb 15]. Available from URL: http://care.diabetesjournals.org/content/38/Supplement_1/S8.full.

4. 2015 Position Statement on Foundations of Care: Education, Nutrition, Physical Activity, Smoking Cessation, Psychosocial Care, and Immunization. American Diabetes Association [cited 2015 Feb 16]. Available from URL: http://care.diabetesjournals.org/content/38/Supplement_1/S20.full.

5. Evert AB, Boucher JL, Cypress M, et al., American Diabetes Association. Nutrition Therapy Recommendations for the Management of Adults With Diabetes. Diabetes Care 2013. 36(11):3821-42.

6. Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association. American Diabetes Association [cited 2015 Feb 16]. Available from URL: http://care.diabetesjournals.org/content/37/7/2034.

7. Gomes M, Negrato C. Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases. Diabetol Metab Syndr 2014;6:80.

8. Garcia-Alcala H, Santos Vichido C, Islas Macedo S, et al. Treatment with alpha-Lipoic Acid over 16 Weeks in Type 2 Diabetic Patients with Symptomatic Polyneuropathy Who Responded to Initial 4-Week High-Dose Loading. J Diabetes Res 2015;2015:189857.

9. Ziegler D, Low P, Litchy W, et al. Efficacy and safety of antioxidant treatment with alpha-lipoic acid over 4 years in diabetic polyneuropathy: the NATHAN 1 trial. Diabetes Care 2011;34:2054–60.

10. Udupa A, Nahar P, Shah S, et al. A comparative study of effects of omega-3 Fatty acids, alpha lipoic Acid and vitamin e in type 2 diabetes mellitus. Ann Med Health Sci Res 2013;3:442–6.

11. Zhao L, Hu F. Alpha-Lipoic acid treatment of aged type 2 diabetes mellitus complicated with acute cerebral infarction. Eur Rev Med Pharmacol Sci 2014;18:3715–9.

12. Okanovic A, Prnjavorac B, Jusufovic E, Sejdinovic R. Alpha-lipoic acid reduces body weight and regulates triglycerides in obese patients with diabetes mellitus. Med Glas (Zenica) 2015;12:122–7.

13. Nebbioso M, Pranno F, Pescosolido N. Lipoic acid in animal models and clinical use in diabetic retinopathy. Expert Opin Pharmacother 2013;14:1829–38.

14. Gebka A, Serkies-Minuth E, Raczynska D. Effect of the administration of alpha-lipoic acid on contrast sensitivity in patients with type 1 and type 2 diabetes. Mediators Inflamm 2014;2014:131538.

15. Hong Y, Peng J, Cai X, et al. Clinical Efficacy of Alprostadil Combined with alpha-lipoic Acid in the Treatment of Elderly Patients with Diabetic Nephropathy. Open Med (Wars) 2017;12:323–7.

16. Mitkov M, Aleksandrova I, Orbetzova M. Effect of transdermal testosterone or alpha-lipoic acid on erectile dysfunction and quality of life in patients with type 2 diabetes mellitus. Folia Med (Plovdiv) 2013;55:55–63.

17. Hosseinzadeh P, Javanbakht M, Mostafavi S, et al. Brewer's Yeast Improves Glycemic Indices in Type 2 Diabetes Mellitus. Int J Prev Med 2013;4:1131–8.

18. Ngala R, Awe M, Nsiah P. The effects of plasma chromium on lipid profile, glucose metabolism and cardiovascular risk in type 2 diabetes mellitus. A case - control study. PLoS One 2018;13:e0197977.

19. Khosravi-Boroujeni H, Rostami A, Ravanshad S, Esmaillzadeh A. Favorable effects on metabolic risk factors with daily brewer's yeast in type 2 diabetic patients with hypercholesterolemia: a semi-experimental study. J Diabetes 2012;4:153–8.

20. Sharma S, Agrawal RP, Choudhary M, et al. Beneficial effect of chromium supplementation on glucose, HbA1C and lipid variables in individuals with newly onset type-2 diabetes. J Trace Elem Med Biol 2011;25:149–53.

21. Bahijiri S, Mira S, Mufti A, Ajabnoor M. The effects of inorganic chromium and brewer's yeast supplementation on glucose tolerance, serum lipids and drug dosage in individuals with type 2 diabetes. Saudi Med J 2000;21:831–7.

22. Racek J, Sindberg C, Moesgaard S, et al. Effect of chromium-enriched yeast on fasting plasma glucose, glycated hemoglobin and serum lipid levels in patients with type 2 diabetes mellitus treated with insulin. Biol Trace Elem Res 2013;155:1–4.

23. Yanni A, Stamataki N, Konstantopoulos P, et al. Controlling type-2 diabetes by inclusion of Cr-enriched yeast bread in the daily dietary pattern: a randomized clinical trial. Eur J Nutr 2018;57:259–67.

24. Chen S, Jin X, Shan Z, et al. Inverse Association of Plasma Chromium Levels with Newly Diagnosed Type 2 Diabetes: A Case-Control Study. Nutrients 2017;9.

25. McIver D, Grizales A, Brownstein J, Goldfine A. Risk of Type 2 Diabetes Is Lower in US Adults Taking Chromium-Containing Supplements. J Nutr 2015;145:2675–82.

26. Ngala R, Awe M, Nsiah P. The effects of plasma chromium on lipid profile, glucose metabolism and cardiovascular risk in type 2 diabetes mellitus. A case - control study. PLoS One 2018;13:e0197977.

27. Rajendran K, Manikandan S, Nair L, et al. Serum Chromium Levels in Type 2 Diabetic Patients and Its Association with Glycaemic Control. J Clin Diagn Res 2015;9:Oc05–8.

28. Farrokhian A, Mahmoodian M, Bahmani F, et al. The Influences of Chromium Supplementation on Metabolic Status in Patients with Type 2 Diabetes Mellitus and Coronary Heart Disease. Biol Trace Elem Res 2019.

29. Huang H, Chen G, Dong Y, et al. Chromium supplementation for adjuvant treatment of type 2 diabetes mellitus: Results from a pooled analysis. Mol Nutr Food Res 2018;62.

30. Brownley K, Boettiger C, Young L, Cefalu W. Dietary chromium supplementation for targeted treatment of diabetes patients with comorbid depression and binge eating. Med Hypotheses 2015;85:45–8.

31. Koupy D, Kotolova H, Ruda Kucerova J. Effectiveness of phytotherapy in supportive treatment of type 2 diabetes mellitus II. Fenugreek (Trigonella foenum-graecum). Ceska Slov Farm 2015;64:67–71.

32. Kiss R, Szabo K, Gesztelyi R, et al. Insulin-Sensitizer Effects of Fenugreek Seeds in Parallel with Changes in Plasma MCH Levels in Healthy Volunteers. Int J Mol Sci 2018;19.

33. Ranade M, Mudgalkar N. A simple dietary addition of fenugreek seed leads to the reduction in blood glucose levels: A parallel group, randomized single-blind trial. Ayu 2017;38:24–7.

34. Gaddam A, Galla C, Thummisetti S, et al. Role of Fenugreek in the prevention of type 2 diabetes mellitus in prediabetes. J Diabetes Metab Disord 2015;14:74.

35. Verma N, Usman K, Patel N, et al. A multicenter clinical study to determine the efficacy of a novel fenugreek seed (Trigonella foenum-graecum) extract (Fenfuro) in patients with type 2 diabetes. Food Nutr Res /em> 2016;60:32382.

36. Neelakantan N, Narayanan M, de Souza R, van Dam R. Effect of fenugreek (Trigonella foenum-graecum L.) intake on glycemia: a meta-analysis of clinical trials. Nutr J 2014;13:7.

37. Weickert M, Pfeiffer A. Impact of Dietary Fiber Consumption on Insulin Resistance and the Prevention of Type 2 Diabetes. J Nutr 2018;148:7–12.

38. Davison K, Temple N. Cereal fiber, fruit fiber, and type 2 diabetes: Explaining the paradox. J Diabetes Complications 2018;32:240–5.

39. Wang Y, Duan Y, Zhu L, et al. Whole grain and cereal fiber intake and the risk of type 2 diabetes: a meta-analysis. Int J Mol Epidemiol Genet 2019;10:38–46.

40. Silva F, Kramer C, de Almeida J, et al. Fiber intake and glycemic control in patients with type 2 diabetes mellitus: a systematic review with meta-analysis of randomized controlled trials. Nutr Rev 2013;71:790–801.

41. Jovanovski E, Khayyat R, Zurbau A, et al. Should Viscous Fiber Supplements Be Considered in Diabetes Control? Results from a Systematic Review and Meta-analysis of Randomized Controlled Trials. Diabetes Care 2019;42:755–66.

42. Gibb R, McRorie J, Jr., Russell D, et al. Psyllium fiber improves glycemic control proportional to loss of glycemic control: a meta-analysis of data in euglycemic subjects, patients at risk of type 2 diabetes mellitus, and patients being treated for type 2 diabetes mellitus. Am J Clin Nutr 2015;102:1604–14.

43. He L, Zhao J, Huang Y, Li Y. The difference between oats and beta-glucan extract intake in the management of HbA1c, fasting glucose and insulin sensitivity: a meta-analysis of randomized controlled trials. Food Funct 2016;7:1413–28.

44. Dall'Alba V, Silva F, Antonio J, et al. Improvement of the metabolic syndrome profile by soluble fibre - guar gum - in patients with type 2 diabetes: a randomised clinical trial. Br J Nutr 2013;110:1601–10.

45. Liu F, Prabhakar M, Ju J, et al. Effect of inulin-type fructans on blood lipid profile and glucose level: a systematic review and meta-analysis of randomized controlled trials. Eur J Clin Nutr 2017;71:9–20.

46. Tinelli C, Di Pino A, Ficulle E, et al. Hyperhomocysteinemia as a Risk Factor and Potential Nutraceutical Target for Certain Pathologies. Front Nutr 2019;6:49.

47. Zhao J, Schooling C, Zhao J. The effects of folate supplementation on glucose metabolism and risk of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Ann Epidemiol 2018;28:249–57.e241.

48. Xu C, Wu Y, Liu G, et al. Relationship between homocysteine level and diabetic retinopathy: a systematic review and meta-analysis. Diagn Pathol 2014;9:167.

49. Mao S, Xiang W, Huang S, Zhang A. Association between homocysteine status and the risk of nephropathy in type 2 diabetes mellitus. Clin Chim Acta 2014;431:206–10.

50. Sudchada P, Saokaew S, Sridetch S, et al. Effect of folic acid supplementation on plasma total homocysteine levels and glycemic control in patients with type 2 diabetes: a systematic review and meta-analysis. Diabetes Res Clin Pract 2012;98:151–8.

51. Smolek M, Notaroberto N, Jaramillo A, Pradillo L. Intervention with vitamins in patients with nonproliferative diabetic retinopathy: a pilot study. Clin Ophthalmol 2013;7:1451–8.

52. Fonseca V, Lavery L, Thethi T, et al. Metanx in type 2 diabetes with peripheral neuropathy: a randomized trial. Am J Med 2013;126:141–9.

53. Jacobs A, Cheng D. Management of diabetic small-fiber neuropathy with combination L-methylfolate, methylcobalamin, and pyridoxal 5'-phosphate. Rev Neurol Dis 2011;8:39–47.

54. Walker M, Jr., Morris L, Cheng D. Improvement of cutaneous sensitivity in diabetic peripheral neuropathy with combination L-methylfolate, methylcobalamin, and pyridoxal 5'-phosphate. Rev Neurol Dis 2010;7:132–9.

55. Chearskul S, Sangurai S, Nitiyanant W, et al. Glycemic and lipid responses to glucomannan in Thais with type 2 diabetes mellitus. J Med Assoc Thai 2007;90:2150–7.

56. Yoshida M, Vanstone C, Parsons W, et al. Effect of plant sterols and glucomannan on lipids in individuals with and without type II diabetes. Eur J Clin Nutr 2006;60:529–37.

57. Chen H, Sheu W, Tai T, et al. Konjac supplement alleviated hypercholesterolemia and hyperglycemia in type 2 diabetic subjects--a randomized double-blind trial. J Am Coll Nutr 2003;22:36–42.

58. Chen H, Nie Q, Hu J, et al. Glucomannans Alleviated the Progression of Diabetic Kidney Disease by Improving Kidney Metabolic Disturbance. Mol Nutr Food Res 2019;63:e1801008.

59. Ozcaliskan Ilkay H, Sahin H, Tanriverdi F, Samur G. Association Between Magnesium Status, Dietary Magnesium Intake, and Metabolic Control in Patients with Type 2 Diabetes Mellitus. J Am Coll Nutr 2019;38:31–9.

60. Hruby A, Guasch-Ferre M, Bhupathiraju S, et al. Magnesium Intake, Quality of Carbohydrates, and Risk of Type 2 Diabetes: Results From Three U.S. Cohorts. Diabetes Care 2017;40:1695–702.

61. Chen S, Jin X, Liu J, et al. Association of Plasma Magnesium with Prediabetes and Type 2 Diabetes Mellitus in Adults. Sci Rep 2017;7:12763.

62. Fang X, Han H, Li M, et al. Dose-Response Relationship between Dietary Magnesium Intake and Risk of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Regression Analysis of Prospective Cohort Studies. Nutrients 2016;8.

63. Kostov K. Effects of Magnesium Deficiency on Mechanisms of Insulin Resistance in Type 2 Diabetes: Focusing on the Processes of Insulin Secretion and Signaling. Int J Mol Sci 2019;20.

64. Barbagallo M, Dominguez L. Magnesium and type 2 diabetes. World J Diabetes 2015;6:1152–7.

65. Kumar P, Bhargava S, Agarwal P, et al. Association of serum magnesium with type 2 diabetes mellitus and diabetic retinopathy. J Family Med Prim Care 2019;8:1671–7.

66. Joy S, George T, Siddiqui K. Low magnesium level as an indicator of poor glycemic control in type 2 diabetic patients with complications. Diabetes Metab Syndr 2019;13:1303–7.

67. Zhang Q, Ji L, Zheng H, et al. Low serum phosphate and magnesium levels are associated with peripheral neuropathy in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2018;146:1–7.

68. Gant C, Soedamah-Muthu S, Binnenmars S, et al. Higher Dietary Magnesium Intake and Higher Magnesium Status Are Associated with Lower Prevalence of Coronary Heart Disease in Patients with Type 2 Diabetes. Nutrients 2018;10.

69. Bherwani S, Jibhkate S, Saumya A, et al. Hypomagnesaemia: a modifiable risk factor of diabetic nephropathy. Horm Mol Biol Clin Investig 2017;29:79–84.

70. Dibaba D, Xun P, Song Y, et al. The effect of magnesium supplementation on blood pressure in individuals with insulin resistance, prediabetes, or noncommunicable chronic diseases: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2017;106:921–9.

71. Verma H, Garg R. Effect of magnesium supplementation on type 2 diabetes associated cardiovascular risk factors: a systematic review and meta-analysis. J Hum Nutr Diet 2017;30:621–33.

72. ELDerawi W, Naser I, Taleb M, Abutair A. The Effects of Oral Magnesium Supplementation on Glycemic Response among Type 2 Diabetes Patients. Nutrients 2018;11.

73. Talari H, Zakizade M, Soleimani A, et al. Effects of magnesium supplementation on carotid intima-media thickness and metabolic profiles in diabetic haemodialysis patients: a randomised, double-blind, placebo-controlled trial. Br J Nutr 2019;121:809–17.

74. Sadeghian M, Azadbakht L, Khalili N, et al. Oral Magnesium Supplementation Improved Lipid Profile but Increased Insulin Resistance in Patients with Diabetic Nephropathy: a Double-Blind Randomized Controlled Clinical Trial. Biol Trace Elem Res 2019.

75. He J, Zhang F, Han Y. Effect of probiotics on lipid profiles and blood pressure in patients with type 2 diabetes: A meta-analysis of RCTs. Medicine (Baltimore) 2017;96:e9166.

76. Wang X, Juan Q, He Y, et al. Multiple effects of probiotics on different types of diabetes: a systematic review and meta-analysis of randomized, placebo-controlled trials. J Pediatr Endocrinol Metab 2017;30:611–22.

77. Hu Y, Zhou F, Yuan Y, Xu Y. Effects of probiotics supplement in patients with type 2 diabetes mellitus: A meta-analysis of randomized trials. Med Clin (Barc) 2017;148:362–70.

78. Akbari V, Hendijani F. Effects of probiotic supplementation in patients with type 2 diabetes: systematic review and meta-analysis. Nutr Rev 2016;74:774–84.

79. Li C, Li X, Han H, et al. Effect of probiotics on metabolic profiles in type 2 diabetes mellitus: A meta-analysis of randomized, controlled trials. Medicine (Baltimore) 2016;95:e4088.

80. Tiderencel K, Hutcheon D, Ziegler J. Probiotics for the treatment of type 2 diabetes: A review of randomized controlled trials. Diabetes Metab Res Rev 2019:e3213.

81. Gibb R, McRorie J, Jr., Russell D, et al. Psyllium fiber improves glycemic control proportional to loss of glycemic control: a meta-analysis of data in euglycemic subjects, patients at risk of type 2 diabetes mellitus, and patients being treated for type 2 diabetes mellitus. Am J Clin Nutr 2015;102:1604–14.

82. Huseini H, Kianbakht S, Hajiaghaee R, Dabaghian F. Anti-hyperglycemic and anti-hypercholesterolemic effects of Aloe vera leaf gel in hyperlipidemic type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Planta Med 2012;78:311–6.

83. Choudhary M, Kochhar A, Sangha J. Hypoglycemic and hypolipidemic effect of Aloe vera L. in non-insulin dependent diabetics. J Food Sci Technol 2014;51:90–6.

84. De Souza L, Jenkins A, Jovanovski E, et al. Ethanol extraction preparation of American ginseng (Panax quinquefolius L) and Korean red ginseng (Panax ginseng C.A. Meyer): differential effects on postprandial insulinemia in healthy individuals. J Ethnopharmacol 2015;159:55–61.

85. Shishtar E, Sievenpiper J, Djedovic V, et al. The effect of ginseng (the genus panax) on glycemic control: a systematic review and meta-analysis of randomized controlled clinical trials. PLoS One 2014;9:e107391.

86. Gui Q, Xu Z, Xu K, Yang Y. The Efficacy of Ginseng-Related Therapies in Type 2 Diabetes Mellitus: An Updated Systematic Review and Meta-analysis. Medicine (Baltimore) 2016;95:e2584.

87. Vuksan V, Xu Z, Jovanovski E, et al. Efficacy and safety of American ginseng (Panax quinquefolius L.) extract on glycemic control and cardiovascular risk factors in individuals with type 2 diabetes: a double-blind, randomized, cross-over clinical trial. Eur J Nutr 2019;58:1237–45.

88. Mucalo I, Jovanovski E, Rahelic D, et al. Effect of American ginseng (Panax quinquefolius L.) on arterial stiffness in subjects with type-2 diabetes and concomitant hypertension. J Ethnopharmacol 2013;150:148–53.

89. Mucalo I, Jovanovski E, Vuksan V, et al. American Ginseng Extract (Panax quinquefolius L.) Is Safe in Long-Term Use in Type 2 Diabetic Patients. Evid Based Complement Alternat Med 2014;2014:969168.

90. Gui Q, Xu Z, Xu K, Yang Y. The Efficacy of Ginseng-Related Therapies in Type 2 Diabetes Mellitus: An Updated Systematic Review and Meta-analysis. Medicine (Baltimore) 2016;95:e2584.

91. Shishtar E, Sievenpiper J, Djedovic V, et al. The effect of ginseng (the genus panax) on glycemic control: a systematic review and meta-analysis of randomized controlled clinical trials. PLoS One 2014;9:e107391.

92. Oh M, Park S, Kim S, et al. Postprandial glucose-lowering effects of fermented red ginseng in subjects with impaired fasting glucose or type 2 diabetes: a randomized, double-blind, placebo-controlled clinical trial. BMC Complement Altern Med 2014;14:237.

93. Zhou P, Xie W, He S, et al. Ginsenoside Rb1 as an Anti-Diabetic Agent and Its Underlying Mechanism Analysis. Cells 2019;8.

94. Bai L, Gao J, Wei F, et al. Therapeutic Potential of Ginsenosides as an Adjuvant Treatment for Diabetes. Front Pharmacol 2018;9:423.

95. Bang H, Kwak JH, Ahn HY, et al. Korean red ginseng improves glucose control in subjects with impaired fasting glucose, impaired glucose tolerance, or newly diagnosed type 2 diabetes mellitus. J Med Food 2014;17:128–34.

96. Yoon J, Kang S, Vassy J, et al. Efficacy and safety of ginsam, a vinegar extract from Panax ginseng, in type 2 diabetic patients: Results of a double-blind, placebo-controlled study. J Diabetes Investig 2012;3:309–17.

97. Vuksan V, Sung M, Sievenpiper J, et al. Korean red ginseng (Panax ginseng) improves glucose and insulin regulation in well-controlled, type 2 diabetes: results of a randomized, double-blind, placebo-controlled study of efficacy and safety. Nutr Metab Cardiovasc Dis 2008;18:46–56.

98. Guo H, Ling W. The update of anthocyanins on obesity and type 2 diabetes: experimental evidence and clinical perspectives. Rev Endocr Metab Disord 2015;16:1–13.

99. Rozanska D, Regulska-Ilow B. The significance of anthocyanins in the prevention and treatment of type 2 diabetes. Adv Clin Exp Med 2018;27:135–42.

100. Karcheva-Bahchevanska D, Lukova P, Nikolova M, et al. Effect of Extracts of Bilberries (Vaccinium myrtillus L.) on Amyloglucosidase and alpha-Glucosidase Activity. Folia Med (Plovdiv) 2017;59:197–202.

101. Guo X, Yang B, Tan J, et al. Associations of dietary intakes of anthocyanins and berry fruits with risk of type 2 diabetes mellitus: a systematic review and meta-analysis of prospective cohort studies. Eur J Clin Nutr 2016;70:1360–7.

102. Rocha D, Caldas A, da Silva B, et al. Effects of blueberry and cranberry consumption on type 2 diabetes glycemic control: A systematic review. Crit Rev Food Sci Nutr 2019;59:1816–28.

103. Burton-Freeman B, Brzezinski M, Park E, et al. A Selective Role of Dietary Anthocyanins and Flavan-3-ols in Reducing the Risk of Type 2 Diabetes Mellitus: A Review of Recent Evidence. Nutrients 2019;11.

104. Cao H, Ou J, Chen L, et al. Dietary polyphenols and type 2 diabetes: Human Study and Clinical Trial. Crit Rev Food Sci Nutr 2018:1-9.

105. Yang L, Ling W, Du Z, et al. Effects of Anthocyanins on Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Adv Nutr 2017;8:684–93.

106. de Mello V, Lankinen M, Lindstrom J, et al. Fasting serum hippuric acid is elevated after bilberry (Vaccinium myrtillus) consumption and associates with improvement of fasting glucose levels and insulin secretion in persons at high risk of developing type 2 diabetes. Mol Nutr Food Res 2017;61.

107. Hoggard N, Cruickshank M, Moar K, et al. A single supplement of a standardized bilberry (Vaccinium myrtillus L.) extract (36 % wet weight anthocyanins) modifies glycaemic response in individuals with type 2 diabetes controlled by diet and lifestyle. J Nutr Sci 2013;2:e22.

108. Ghosh D, Konishi T. Anthocyanins and anthocyanin-rich extracts: role in diabetes and eye function. Asia Pac J Clin Nutr 2007;16:200–8.

109. Maebashi M, Makino Y, Furukawa Y, et al. Therapeutic evaluation of the effect of biotin on hyperglycemia in patients with non-insulin dependent diabetes mellitus. J Clin Biochem Nutr 1993;14:211–8

110. Revilla-Monsalve C, Zendejas-Ruiz I, Islas-Andrade S, et al. Biotin supplementation reduces plasma triacylglycerol and VLDL in type 2 diabetic patients and in nondiabetic subjects with hypertriglyceridemia. Biomed Pharmacother 2006;60:182–5.

111. Koutsikos D, Agroyannis B, Tzanatos-Exarchou H. Biotin for diabetic peripheral neuropathy. Biomed Pharmacother 1990;44:511–4.

112. Singer G, Geohas J. The effect of chromium picolinate and biotin supplementation on glycemic control in poorly controlled patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized trial. Diabetes Technol Ther 2006;8:636–43.

113. Albarracin C, Fuqua B, Geohas J, et al. Combination of chromium and biotin improves coronary risk factors in hypercholesterolemic type 2 diabetes mellitus: a placebo-controlled, double-blind randomized clinical trial. J Cardiometab Syndr 2007;2:91–7.

114. Geohas J, Daly A, Juturu V, et al. Chromium picolinate and biotin combination reduces atherogenic index of plasma in patients with type 2 diabetes mellitus: a placebo-controlled, double-blinded, randomized clinical trial. Am J Med Sci 2007;333:145–53.

115. Albarracin C, Fuqua B, Evans J, Goldfine I. Chromium picolinate and biotin combination improves glucose metabolism in treated, uncontrolled overweight to obese patients with type 2 diabetes. Diabetes Metab Res Rev 2008;24:41–51.

116. Shivanagoudra S, Perera W, Perez J, et al. In vitro and in silico elucidation of antidiabetic and anti-inflammatory activities of bioactive compounds from Momordica charantia L. Bioorg Med Chem 2019;27:3097–109.

117. Yin R, Lee N, Hirpara H, Phung O. The effect of bitter melon (Mormordica charantia) in patients with diabetes mellitus: a systematic review and meta-analysis. Nutr Diabetes 2014;4:e145.

118. Ooi C, Yassin Z, Hamid T. Momordica charantia for type 2 diabetes mellitus. Cochrane Database Syst Rev 2012:Cd007845.

119. Peter E, Kasali F, Deyno S, et al. Momordica charantia L. lowers elevated glycaemia in type 2 diabetes mellitus patients: Systematic review and meta-analysis. J Ethnopharmacol 2019;231:311–24.

120. Cortez-Navarrete M, Martínez-Abundis E, Perez-Rubio K, et al. Momordica charantia Administration Improves Insulin Secretion in Type 2 Diabetes Mellitus. J Med Food 2018;21:672–7.

121. Inayat U, Khan R, Khalil Ur R, Bashir M. Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients. Nutr J 2015;14:13.

122. Mang B, Wolters M, Schmitt B, et al. Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2. Eur J Clin Invest 2006;36:340–4.

123. Crawford P. Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: a randomized, controlled trial. J Am Board Fam Med 2009;22:507–12.

124. Akilen R, Tsiami A, Devendra D, Robinson N. Glycated haemoglobin and blood pressure-lowering effect of cinnamon in multi-ethnic Type 2 diabetic patients in the UK: a randomized, placebo-controlled, double-blind clinical trial. Diabet Med 2010;27:1159–67.

125. Lu T, Sheng H, Wu J, et al. Cinnamon extract improves fasting blood glucose and glycosylated hemoglobin level in Chinese patients with type 2 diabetes. Nutr Res 2012;32:408–12.

126. Sahib A. Anti-diabetic and antioxidant effect of cinnamon in poorly controlled type-2 diabetic Iraqi patients: A randomized, placebo-controlled clinical trial. J Intercult Ethnopharmacol 2016;5:108–13.

127. Sengsuk C, Sanguanwong S, Tangvarasittichai O, Tangvarasittichai S. Effect of cinnamon supplementation on glucose, lipids levels, glomerular filtration rate, and blood pressure of subjects with type 2 diabetes mellitus. Diabetol Int 2016;7:124–32.

128. Talaei B, Amouzegar A, Sahranavard S, et al. Effects of Cinnamon Consumption on Glycemic Indicators, Advanced Glycation End Products, and Antioxidant Status in Type 2 Diabetic Patients. Nutrients 2017;9.

129. Deyno S, Eneyew K, Seyfe S, et al. Efficacy and safety of cinnamon in type 2 diabetes mellitus and pre-diabetes patients: A meta-analysis and meta-regression. Diabetes Res Clin Pract 2019;156:107815.

130. Namazi N, Khodamoradi K, Khamechi S, et al. The impact of cinnamon on anthropometric indices and glycemic status in patients with type 2 diabetes: A systematic review and meta-analysis of clinical trials. Complement Ther Med 2019;43:92–101.

131. Yen C, Chu Y, Lee B, et al. Effect of liquid ubiquinol supplementation on glucose, lipids and antioxidant capacity in type 2 diabetes patients: a double-blind, randomised, placebo-controlled trial. Br J Nutr 2018;120:57–63.

132. Raygan F, Rezavandi Z, Dadkhah Tehrani S, et al The effects of coenzyme Q10 administration on glucose homeostasis parameters, lipid profiles, biomarkers of inflammation and oxidative stress in patients with metabolic syndrome. Eur J Nutr 2016;55:2357–64.

133. Zahedi H, Eghtesadi S, Seifirad S, et al. Effects of CoQ10 Supplementation on Lipid Profiles and Glycemic Control in Patients with Type 2 Diabetes: a randomized, double blind, placebo-controlled trial. J Diabetes Metab Disord 2014;13:81.

134. Kolahdouz Mohammadi R, Hosseinzadeh-Attar M, Eshraghian M, et al. The effect of coenzyme Q10 supplementation on metabolic status of type 2 diabetic patients. Minerva Gastroenterol Dietol 2013;59:231–6.

135. Mezawa M, Takemoto M, Onishi S, et al. The reduced form of coenzyme Q10 improves glycemic control in patients with type 2 diabetes: an open label pilot study. Biofactors 2012;38:416–21.

136. Zhang S, Yang K, Zeng L, et al. Effectiveness of Coenzyme Q10 Supplementation for Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Int J Endocrinol 2018;2018:6484839.

137. Huang H, Chi H, Liao D, Zou Y. Effects of coenzyme Q10 on cardiovascular and metabolic biomarkers in overweight and obese patients with type 2 diabetes mellitus: a pooled analysis. Diabetes Metab Syndr Obes 2018;11:875–86.

138. Akbari Fakhrabadi M, Zeinali Ghotrom A, Mozaffari-Khosravi H, et al. Effect of Coenzyme Q10 on Oxidative Stress, Glycemic Control and Inflammation in Diabetic Neuropathy: A Double Blind Randomized Clinical Trial. Int J Vitam Nutr Res 2014;84:252–60.

139. Stohs S, Miller H, Kaats G. A review of the efficacy and safety of banaba (Lagerstroemia speciosa L.) and corosolic acid. Phytother Res 2012;26:317–24.

140. Judy W, Hari S, Stogsdill W, et al. Antidiabetic activity of a standardized extract (Glucosol) from Lagerstroemia speciosa leaves in Type II diabetics. A dose-dependence study. J Ethnopharmacol 2003;87:115–7.

141. Casanova E, Salvado J, Crescenti A, Gibert-Ramos A. Epigallocatechin Gallate Modulates Muscle Homeostasis in Type 2 Diabetes and Obesity by Targeting Energetic and Redox Pathways: A Narrative Review. Int J Mol Sci 2019;20.

142. Yang C, Zhang J, Zhang L, et al. Mechanisms of body weight reduction and metabolic syndrome alleviation by tea. Mol Nutr Food Res 2016;60:160–74.

143. Ferreira M, Silva D, de Morais A, et al. Therapeutic potential of green tea on risk factors for type 2 diabetes in obese adults - a review. Obes Rev 2016;17:1316–28.

144. Keske M, Ng H, Premilovac D, et al. Vascular and metabolic actions of the green tea polyphenol epigallocatechin gallate. Curr Med Chem 2015;22:59–69.

145. Quezada-Fernandez P, Trujillo-Quiros J, Pascoe-Gonzalez S, et al. Effect of green tea extract on arterial stiffness, lipid profile and sRAGE in patients with type 2 diabetes mellitus: a randomised, double-blind, placebo-controlled trial. Int J Food Sci Nutr 2019:1–9.

146. Liu K, Zhou R, Wang B, et al. Effect of green tea on glucose control and insulin sensitivity: a meta-analysis of 17 randomized controlled trials. Am J Clin Nutr 2013;98:340–8.

147. Yu J, Song P, Perry R, et al. The Effectiveness of Green Tea or Green Tea Extract on Insulin Resistance and Glycemic Control in Type 2 Diabetes Mellitus: A Meta-Analysis. Diabetes Metab J 2017;41:251–62.

148. Younes M, Aggett P, Aguilar F, et al. Scientific opinion on the safety of green tea catechins. EFSA Journal 2018;16:e05239.

149. Pothuraju R, Sharma R, Chagalamarri J, et al. A systematic review of Gymnema sylvestre in obesity and diabetes management. J Sci Food Agric 2014;94:834–40.

150. Baskaran K, Kizar Ahamath B, Radha Shanmugasundaram K, Shanmugasundaram E. Antidiabetic effect of a leaf extract from Gymnema sylvestre in non-insulin-dependent diabetes mellitus patients. J Ethnopharmacol 1990;30:295–300.

151. Kumar S, Mani U, Mani I. An open label study on the supplementation of Gymnema sylvestre in type 2 diabetics. J Diet Suppl 2010;7:273–82.

152. Al-Romaiyan A, Liu B, Asare-Anane H, et al. A novel Gymnema sylvestre extract stimulates insulin secretion from human islets in vivo and in vitro. Phytother Res 2010;24:1370–6.

153. Li Y, Zheng M, Zhai X, et al. Effect of Gymnema sylvestre, Citrus colocynthis and Artemisia absinthum on blood glucose and lipid profile in diabetic human. Acta Pol Pharm 2015;72:981–5.

154. Ononamadu C, Alhassan A, Imam A, et al. In vitro and in vivo anti-diabetic and anti-oxidant activities of methanolic leaf extracts of Ocimum canum. Caspian J Intern Med 2019;10:162–75.

155. Nyarko A, Asare-Anane H, Ofosuhene M, et al. Aqueous extract of Ocimum canum decreases levels of fasting blood glucose and free radicals and increases antiatherogenic lipid levels in mice. Vascul Pharmacol 2002;39:273–9.

156. Nyarko A, Asare-Anane H, Ofosuhene M, Addy M. Extract of Ocimum canum lowers blood glucose and facilitates insulin release by isolated pancreatic beta-islet cells. Phytomedicine 2002;9:346–51.

157. Viseshakul D, Premvatana P, Chularojmontri V, et al. Improved glucose tolerance induced by long term dietary supplementation with hairy basal seeds (Ocimum canum Sim) in diabetics. J Med Assoc Thailand 1985;68:408–11.

158. Suanarunsawat T, Anantasomboon G, Piewbang C. Anti-diabetic and anti-oxidative activity of fixed oil extracted from Ocimum sanctum L. leaves in diabetic rats. Exp Ther Med 2016;11:832–40.

159. Husain I, Chander R, Saxena J, et al. Antidyslipidemic Effect of Ocimum sanctum Leaf Extract in Streptozotocin Induced Diabetic Rats. Indian J Clin Biochem 2015;30:72–7.

160. Muralikrishnan G, Pillai S, Shakeel F. Protective effects of Ocimum sanctum on lipid peroxidation and antioxidant status in streptozocin-induced diabetic rats. Nat Prod Res 2012;26:474–8.

161. Patil R, Patil R, Ahirwar B, Ahirwar D. Isolation and characterization of anti-diabetic component (bioactivity-guided fractionation) from Ocimum sanctum L. (Lamiaceae) aerial part. Asian Pac J Trop Med 2011;4:278–82.

162. Agrawal P, Rai V, Singh RB. Randomized placebo-controlled, single blind trial of holy basil leaves in patients with noninsulin-dependent diabetes mellitus. Int J Clin Pharmacol Ther 1996;34:406–9.

163. Satapathy S, Das N, Bandyopadhyay D, et al. Effect of Tulsi (Ocimum sanctum Linn.) Supplementation on Metabolic Parameters and Liver Enzymes in Young Overweight and Obese Subjects. Indian J Clin Biochem 2017;32:357–63.

164. Adeva-Andany M, Calvo-Castro I, Fernandez-Fernandez C, et al. Significance of l-carnitine for human health. IUBMB Life 2017;69:578–94.

165. Bene J, Hadzsiev K, Melegh B. Role of carnitine and its derivatives in the development and management of type 2 diabetes. Nutr Diabetes 2018;8:8.

166. Ramazani M, Qujeq D, Moazezi Z. Assessing the Levels of L-Carnitine and Total Antioxidant Capacity in Adults with Newly Diagnosed and Long-Standing Type 2 Diabetes. Can J Diabetes 2019;43:46-50.e41.

167. Poorabbas A, Fallah F, Bagdadchi J, et al. Determination of free L-carnitine levels in type II diabetic women with and without complications. Eur J Clin Nutr 2007;61:892–5.

168. Ringseis R, Keller J, Eder K. Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency. Eur J Nutr 2012;51:1–18.

169. Vidal-Casariego A, Burgos-Pelaez R, Martinez-Faedo C, et al. Metabolic effects of L-carnitine on type 2 diabetes mellitus: systematic review and meta-analysis. Exp Clin Endocrinol Diabetes 2013;121:234–8.

170. El-Sheikh H, El-Haggar S, Elbedewy T. Comparative study to evaluate the effect of l-carnitine plus glimepiride versus glimepiride alone on insulin resistance in type 2 diabetic patients. Diabetes Metab Syndr 2019;13:167–73.

171. Derosa G, Maffioli P, Ferrari I, et al. Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients. Endocr J 2010;57:777–86.

172. Derosa G, Maffioli P, Salvadeo S, et al. Sibutramine and L-carnitine compared to sibutramine alone on insulin resistance in diabetic patients. Intern Med 2010;49:1717–25.

173. Galvano F, Li Volti G, Malaguarnera M, et al. Effects of simvastatin and carnitine versus simvastatin on lipoprotein(a) and apoprotein(a) in type 2 diabetes mellitus. Expert Opin Pharmacother 2009;10:1875–82.

174. Molfino A, Cascino A, Conte C, et al. Caloric restriction and L-carnitine administration improves insulin sensitivity in patients with impaired glucose metabolism. JPEN J Parenter Enteral Nutr 2010;34:295–9.

175. Imbe A, Tanimoto K, Inaba Y, et al. Effects of L-carnitine supplementation on the quality of life in diabetic patients with muscle cramps. Endocr J 2018;65:521–6.

176. Ebrahimpour-Koujan S, Gargari B, Mobasseri M, et al. Lower glycemic indices and lipid profile among type 2 diabetes mellitus patients who received novel dose of Silybum marianum (L.) Gaertn. (silymarin) extract supplement: A Triple-blinded randomized controlled clinical trial. Phytomedicine 2018;44:39–44.

177. Ebrahimpour Koujan S, Gargari B, Mobasseri M, et al. Effects of Silybum marianum (L.) Gaertn. (silymarin) extract supplementation on antioxidant status and hs-CRP in patients with type 2 diabetes mellitus: a randomized, triple-blind, placebo-controlled clinical trial. Phytomedicine 2015;22:290–6.

178. Huseini H, Larijani B, Heshmat R, et al. The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial. Phytother Res 2006;20:1036–9.

179. Di Pierro F, Bellone I, Rapacioli G, Putignano P. Clinical role of a fixed combination of standardized Berberis aristata and Silybum marianum extracts in diabetic and hypercholesterolemic patients intolerant to statins. Diabetes Metab Syndr Obes 2015;8:89–96.

180. Di Pierro F, Putignano P, Villanova N, et al. Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes. Clin Pharmacol 2013;5:167–74.

181. Ikechukwu O, Ifeanyi O. The Antidiabetic Effects of The Bioactive Flavonoid (Kaempferol-3-O-beta-D-6{P- Coumaroyl} Glucopyranoside) Isolated from Allium cepa.Recent Pat Antiinfect Drug Discov 2016;11:44–52.

182. Oboh G, Ademiluyi A, Agunloye O, et al. Inhibitory Effect of Garlic, Purple Onion, and White Onion on Key Enzymes Linked with Type 2 Diabetes and Hypertension. J Diet Suppl 2019;16:105–18.

183. Akash M, Rehman K, Chen S. Spice plant Allium cepa: dietary supplement for treatment of type 2 diabetes mellitus. Nutrition 2014;30:1128–37.

184. Gautam S, Pal S, Maurya R, Srivastava A. Ethanolic extract of Allium cepa stimulates glucose transporter typ 4-mediated glucose uptake by the activation of insulin signaling. Planta Med 2015;81:208–14.

185. Taj Eldin I, Ahmed E, Elwahab H. Preliminary Study of the Clinical Hypoglycemic Effects of Allium cepa (Red Onion) in Type 1 and Type 2 Diabetic Patients. Environ Health Insights 2010;4:71–7.

186. Tjokroprawiro A, Pikir BS, Budhiarta AA, et al. Metabolic effects of onion and green beans on diabetic patients. Tohoku J Exp Med 1983;141:671–6.

187. Liu X, Zhou HJ, Rohdewald P. French maritime pine bark extract Pycnogenol dose-dependently lowers glucose in type 2 diabetic patients. Diabetes Care 2004;27:839 [letter].

188. Zibadi S, Rohdewald PJ, Park D, Watson RR. Reduction of cardiovascular risk factors in subjects with type 2 diabetes by Pycnogenol supplementation. Nutr Res 2008;28:315–20.

189. Liu X, Wei J, Tan F, et al. Antidiabetic effect of Pycnogenol French maritime pine bark extract in patients with diabetes type II. Life Sci 2004;75:2505–13.

190. Cesarone M, Belcaro G, Rohdewald P, et al. Improvement of diabetic microangiopathy with pycnogenol: A prospective, controlled study. Angiology 2006;57:431–6.

191. Schonlau F, Rohdewald P. Pycnogenol for diabetic retinopathy. A review. Int Ophthalmol 2001;24:161–71.

192. Spadea L, Balestrazzi E. Treatment of vascular retinopathies with Pycnogenol. Phytother Res 2001;15:219–23.

193. Steigerwalt R, Belcaro G, Cesarone MR, et al. Pycnogenol improves microcirculation, retinal edema, and visual acuity in early diabetic retinopathy. J Ocul Pharmacol Ther 2009;25:537–40.

194. Belcaro G, Cesarone M, Errichi B, et al. Diabetic ulcers: microcirculatory improvement and faster healing with pycnogenol. Clin Appl Thromb Hemost 2006;12:318–23.

195. Vinciguerra G, Belcaro G, Cesarone MR, et al. Cramps and muscular pain: prevention with pycnogenol in normal subjects, venous patients, athletes, claudicants and in diabetic microangiopathy. Angiology 2006;57:331–9.

196. Kim H, Park K, Lee S, et al. Effects of pinitol on glycemic control, insulin resistance and adipocytokine levels in patients with type 2 diabetes mellitus. Ann Nutr Metab 2012;60:1–5.

197. Kim J, Kim J, Kang M, et al Effects of pinitol isolated from soybeans on glycaemic control and cardiovascular risk factors in Korean patients with type II diabetes mellitus: a randomized controlled study. Eur J Clin Nutr 2005;59:456–8.

198. Kang M, Kim J, Yoon S, et al. Pinitol from soybeans reduces postprandial blood glucose in patients with type 2 diabetes mellitus. J Med Food 2006;9:182–6.

199. Merigliano C, Mascolo E, Burla R, et al. The Relationship Between Vitamin B6, Diabetes and Cancer. Front Genet 2018;9:388.

200. Kim H, Kang Y, Lee J, et al. The Postprandial Anti-Hyperglycemic Effect of Pyridoxine and Its Derivatives Using In Vitro and In Vivo Animal Models. Nutrients 2018;10.

201. Ahn H, Min K, Cho Y. Assessment of vitamin B(6) status in Korean patients with newly diagnosed type 2 diabetes. Nutr Res Pract 2011;5:34–9.

202. McCann V, Davis R. Serum pyridoxal concentrations in patients with diabetic neuropathy. Aust N Z J Med 1978;8:259–61.

203. Nix W, Zirwes R, Bangert V, et al. Vitamin B status in patients with type 2 diabetes mellitus with and without incipient nephropathy. Diabetes Res Clin Pract 2015;107:157–65.

204. Walker M, Morris L, Cheng D. Improvement of cutaneous sensitivity in diabetic peripheral neuropathy with combination L-methylfolate, methylcobalamin, and pyridoxal 5'-phosphate. Rev Neurol Dis 2010;7:132–9.

205. Smolek M, Notaroberto N, Jaramillo A, Pradillo L. Intervention with vitamins in patients with nonproliferative diabetic retinopathy: a pilot study. Clin Ophthalmol 2013;7:1451–8.

206. Mason S, Rasmussen B, van Loon L, et al. Ascorbic acid supplementation improves postprandial glycaemic control and blood pressure in individuals with type 2 diabetes: Findings of a randomized cross-over trial. Diabetes Obes Metab 2019;21:674–82.

207. Ashor A, Werner A, Lara J, et al. Effects of vitamin C supplementation on glycaemic control: a systematic review and meta-analysis of randomised controlled trials. Eur J Clin Nutr 2017;71:1371–80.

208. Das U. Vitamin C for Type 2 Diabetes Mellitus and Hypertension. Arch Med Res 2019;50:11–4.

209. Franke S, Muller L, Santos M, et al. Vitamin C intake reduces the cytotoxicity associated with hyperglycemia in prediabetes and type 2 diabetes. Biomed Res Int 2013;2013:896536.

210. Rahimi-Madiseh M, Malekpour-Tehrani A, Bahmani M, Rafieian-Kopaei M. The research and development on the antioxidants in prevention of diabetic complications. Asian Pac J Trop Med 2016;9:825–31.

211. May J. Ascorbic acid repletion: A possible therapy for diabetic macular edema? Free Radic Biol Med 2016;94:47–54.

212. Kundu D, Mandal T, Nandi M, et al. Oxidative stress in diabetic patients with retinopathy. Ann Afr Med 2014;13:41–6.

213. Park S, Ghim W, Oh S, et al. Association of vitreous vitamin C depletion with diabetic macular ischemia in proliferative diabetic retinopathy. PLoS One 2019;14:e0218433.

214. Moshetova L, Vorob'eva I, Alekseev I, Mikhaleva L. Results of the use of antioxidant and angioprotective agents in type 2 diabetes patients with diabetic retinopathy and age-related macular degeneration. Vestn Oftalmol. 2015;131:34–44. [in Russian]

215. Cho J, Ahn S, Yim J, et al. Influence of Vitamin C and Maltose on the Accuracy of Three Models of Glucose Meters. Ann Lab Med 2016;36:271–4.

216. Grammatiki M, Karras S, Kotsa K. The role of vitamin D in the pathogenesis and treatment of diabetes mellitus: a narrative review. Hormones (Athens) 2019;18:37–48.

217. Leung P. The Potential Protective Action of Vitamin D in Hepatic Insulin Resistance and Pancreatic Islet Dysfunction in Type 2 Diabetes Mellitus. Nutrients 2016;8:147.

218. Sacerdote A, Dave P, Lokshin V, Bahtiyar G. Type 2 Diabetes Mellitus, Insulin Resistance, and Vitamin D. Curr Diab Rep 2019;19:101.

219. Rafiq S, Jeppesen P. Is Hypovitaminosis D Related to Incidence of Type 2 Diabetes and High Fasting Glucose Level in Healthy Subjects: A Systematic Review and Meta-Analysis of Observational Studies. Nutrients 2018;10.

220. Li X, Liu Y, Zheng Y, et al. The Effect of Vitamin D Supplementation on Glycemic Control in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis. Nutrients 2018;10.

221. Wu C, Qiu S, Zhu X, Li L. Vitamin D supplementation and glycemic control in type 2 diabetes patients: A systematic review and meta-analysis. Metabolism 2017;73:67–76.

222. Lee C, Iyer G, Liu Y, et al. The effect of vitamin D supplementation on glucose metabolism in type 2 diabetes mellitus: A systematic review and meta-analysis of intervention studies. J Diabetes Complications 2017;31:1115–26.

223. Mirhosseini N, Vatanparast H, Mazidi M, Kimball S. The Effect of Improved Serum 25-Hydroxyvitamin D Status on Glycemic Control in Diabetic Patients: A Meta-Analysis. J Clin Endocrinol Metab 2017;102:3097–110.

224. Alam U, Arul-Devah V, Javed S, Malik R. Vitamin D and Diabetic Complications: True or False Prophet? Diabetes Ther 2016;7:11–26.

225. Zhao T, Huang Q, Su Y, et al. Zinc and its regulators in pancreas. Inflammopharmacology 2019;27:453–64.

226. Naik S, Ramanand S, Ramanand J. A Medley Correlation of Serum Zinc with Glycemic Parameters in T2DM Patients. Indian J Endocrinol Metab 2019;23:188–92.

227. Ruz M, Carrasco F, Rojas P, et al. Nutritional Effects of Zinc on Metabolic Syndrome and Type 2 Diabetes: Mechanisms and Main Findings in Human Studies. Biol Trace Elem Res 2019;188:177–88.

228. Ranasinghe P, Wathurapatha W, Galappatthy P, et al. Zinc supplementation in prediabetes: A randomized double-blind placebo-controlled clinical trial. J Diabetes 2018;10:386–97.

229. Fernández-Cao J, Warthon-Medina M, H Moran V, et al. Zinc Intake and Status and Risk of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Nutrients 2019;11.

230. Khan M, Siddique K, Ashfaq F, et al. Effect of high-dose zinc supplementation with oral hypoglycemic agents on glycemic control and inflammation in type-2 diabetic nephropathy patients. J Nat Sci Biol Med 2013;4:336–40.

231. Hussain S, Khadim H, Khalaf B, et al. Effects of melatonin and zinc on glycemic control in type 2 diabetic patients poorly controlled with metformin. Saudi Med J 2006;27:1483–8.

232. Kadhim H, Ismail S, Hussein K, et al. Effects of melatonin and zinc on lipid profile and renal function in type 2 diabetic patients poorly controlled with metformin. J Pineal Res 2006;41:189–93.

233. Udani J, Singh B, Singh V, et al. Effects of Acai (Euterpe oleracea Mart.) berry preparation on metabolic parameters in a healthy overweight population: a pilot study. Nutr J 2011;10:45.

234. de Bem G, Costa C, Santos I, et al. Antidiabetic effect of Euterpe oleracea Mart. (acai) extract and exercise training on high-fat diet and streptozotocin-induced diabetic rats: A positive interaction. PLoS One 2018;13:e0199207.

235. de Bem G, da Costa C, da Silva Cristino Cordeiro V, et al. Euterpe oleracea Mart. (acai) seed extract associated with exercise training reduces hepatic steatosis in type 2 diabetic male rats. J Nutr Biochem 2018;52:70–81.

236. Liu D, Gao H, Tang W, Nie S. Plant non-starch polysaccharides that inhibit key enzymes linked to type 2 diabetes mellitus. Ann N Y Acad Sci 2017;1401:28–36.

237. Tiwari A. Revisiting "Vegetables" to combat modern epidemic of imbalanced glucose homeostasis. Pharmacogn Mag 2014;10:S207–13.

238. Wang H, Liu T, Huang D. Starch hydrolase inhibitors from edible plants. Adv Food Nutr Res 2013;70:103–36.

239. Thompson S, Winham D, Hutchins A. Bean and rice meals reduce postprandial glycemic response in adults with type 2 diabetes: a cross-over study. Nutr J 2012;11:23.

240. Barrett M, Udani J. A proprietary alpha-amylase inhibitor from white bean (Phaseolus vulgaris): a review of clinical studies on weight loss and glycemic control. Nutr J 2011;10:24.

241. Reis C, Dorea J, da Costa T. Effects of coffee consumption on glucose metabolism: A systematic review of clinical trials. J Tradit Complement Med 2019;9:184–91.

242. Rebelo I, Casal S. Coffee: A Dietary Intervention on Type 2 Diabetes? Curr Med Chem 2017;24:376–83.

243. Tunnicliffe J, Shearer J. Coffee, glucose homeostasis, and insulin resistance: physiological mechanisms and mediators. Appl Physiol Nutr Metab 2008;33:1290–300.

244. Henry-Vitrac C, Ibarra A, Roller M. Contribution of chlorogenic acids to the inhibition of human hepatic glucose-6-phosphatase activity in vitro by Svetol, a standardized decaffeinated green coffee extract. J Agric Food Chem 2010;58:4141–4.

245. Ho L, Varghese M, Wang J, et al. Dietary supplementation with decaffeinated green coffee improves diet-induced insulin resistance and brain energy metabolism in mice. Nutr Neurosci 2012;15:37–45.

246. Thom E. The effect of chlorogenic acid enriched coffee on glucose absorption in healthy volunteers and its effect on body mass when used long-term in overweight and obese people J Int Med Res 2007;35:900–8.

247. Omran O. Histopathological study of evening primrose oil effects on experimental diabetic neuropathy. Ultrastruct Pathol 2012;36:222–7.

248. Kim D, Yoo T, Lee S, et al. Gamma linolenic acid exerts anti-inflammatory and anti-fibrotic effects in diabetic nephropathy. Yonsei Med J 2012;53:1165–75.

249. Head R, McLennan P, Raederstorff D, et al. Prevention of nerve conduction deficit in diabetic rats by polyunsaturated fatty acids. Am J Clin Nutr 2000;71:386s–92s.

250. Jamal G, Carmichael H. The effect of gamma-linolenic acid on human diabetic peripheral neuropathy: a double-blind placebo-controlled trial. Diabet Med 1990;7:319–23.

251. Dyer O. GMC accuses doctor of research fraud. BMJ 2003;326:616.

252. Telle-Hansen V, Gaundal L, Myhrstad M. Polyunsaturated Fatty Acids and Glycemic Control in Type 2 Diabetes. Nutrients 2019;11.

253. Abbott K, Burrows T, Thota R, et al. Do omega-3 PUFAs affect insulin resistance in a sex-specific manner? A systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr 2016;104:1470–84.

254. O'Mahoney L, Matu J, Price O, et al. Omega-3 polyunsaturated fatty acids favorably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials. Cardiovasc Diabetol 2018;17:98.

255. Gao H, Geng T, Huang T, Zhao Q. Fish oil supplementation and insulin sensitivity: a systematic review and meta-analysis. Lipids Health Dis 2017;16:131.

256. He M, Shi B. Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics. Cell Biosci 2017;7:54.

257. Colantonio A, Werner S, Brown M. The Effects of Prebiotics and Substances with Prebiotic Properties on Metabolic and Inflammatory Biomarkers in Individuals with Type 2 Diabetes Mellitus: A Systematic Review. J Acad Nutr Diet 2019.

258. Mahboobi S, Rahimi F, Jafarnejad S. Effects of Prebiotic and Synbiotic Supplementation on Glycaemia and Lipid Profile in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials. Adv Pharm Bull 2018;8:565–74.

259. Kudolo G, Wang W, Javors M, Blodgett J. The effect of the ingestion of Ginkgo biloba extract (EGb 761) on the pharmacokinetics of metformin in non-diabetic and type 2 diabetic subjects--a double blind placebo-controlled, crossover study. Clin Nutr 2006;25:606–16.

260. Aziz T, Hussain S, Mahwi T, et al. The efficacy and safety of Ginkgo biloba extract as an adjuvant in type 2 diabetes mellitus patients ineffectively managed with metformin: a double-blind, randomized, placebo-controlled trial. Drug Des Devel Ther 2018;12:735–42.

261. Lu J, He H. Clinical observation of Gingko biloba extract injection in treating early diabetic nephropathy. Chin J Integr Med 2005;11:226–8. [in Chinese]

262. Huang S, Jeng C, Kao S, et al. Improved haemorrheological properties by Ginkgo biloba extract (Egb 761) in type 2 diabetes mellitus complicated with retinopathy. Clin Nutr 2004;23:615–21.

263. Zhao Y, Yu J, Liu J, An X. The Role of Liuwei Dihuang Pills and Ginkgo Leaf Tablets in Treating Diabetic Complications. Evid Based Complement Alternat Med 2016;2016:7931314.

264. da Silva G, Zanoni J, Buttow N. Neuroprotective action of Ginkgo biloba on the enteric nervous system of diabetic rats. World J Gastroenterol 2011;17:898–905.

265. Taliyan R, Sharma P. Protective effect and potential mechanism of Ginkgo biloba extract EGb 761 on STZ-induced neuropathic pain in rats. Phytother Res 2012;26:1823–9.

266. Zhang H, Wei J, Xue R, et al. Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism 2010;59:285-92

267. Giacoman-Martinez A, Alarcon-Aguilar FJ Zamilpa A, et al. Triterpenoids from Hibiscus sabdariffa L. with PPARdelta/gamma Dual Agonist Action: In Vivo, In Vitro and In Silico Studies. Planta Med 2019;85:412–23.

268. Huang C, Wang C, Yang Y, et al. Hibiscus sabdariffa polyphenols prevent palmitate-induced renal epithelial mesenchymal transition by alleviating dipeptidyl peptidase-4-mediated insulin resistance. Food Funct 2016;7:475–82.

269. Peng C, Yang Y, Chan K, et al. Hibiscus sabdariffa polyphenols alleviate insulin resistance and renal epithelial to mesenchymal transition: a novel action mechanism mediated by type 4 dipeptidyl peptidase. J Agric Food Chem 2014;62:9736–43.

270. Ademiluyi A, Oboh G. Aqueous extracts of Roselle (Hibiscus sabdariffa Linn.) varieties inhibit alpha-amylase and alpha-glucosidase activities in vitro. J Med Food 2013;16:88–93.

271. Peng C, Chyau C, Chan K, et al. Hibiscus sabdariffa polyphenolic extract inhibits hyperglycemia, hyperlipidemia, and glycation-oxidative stress while improving insulin resistance. J Agric Food Chem 2011;59:9901–9.

272. Mozaffari-Khosravi H, Jalali-Khanabadi B, Afkhami-Ardekani M, Fatehi F. Effects of sour tea (Hibiscus sabdariffa) on lipid profile and lipoproteins in patients with type II diabetes. J Altern Complement Med 2009;15:899–903.

273. Mozaffari-Khosravi H, Ahadi Z, Barzegar K. The effect of green tea and sour tea on blood pressure of patients with type 2 diabetes: a randomized clinical trial. J Diet Suppl 2013;10:105–15.

274. Mozaffari-Khosravi H, Jalali-Khanabadi B, Afkhami-Ardekani M, et al. The effects of sour tea (Hibiscus sabdariffa) on hypertension in patients with type II diabetes. J Hum Hypertens 2009;23:48–54.

275. Croze M, Soulage C. Potential role and therapeutic interests of myo-inositol in metabolic diseases. Biochimie 2013;95:1811–27.

276. Chukwuma C, Ibrahim M, Islam M. Myo-inositol inhibits intestinal glucose absorption and promotes muscle glucose uptake: a dual approach study. J Physiol Biochem 2016;72:791–801.

277. Gao Y, Zhang M, Wang T, et al. Hypoglycemic effect of D-chiro-inositol in type 2 diabetes mellitus rats through the PI3K/Akt signaling pathway. Mol Cell Endocrinol 2016;433:26–34.

278. Pintaudi B, Di Vieste G, Bonomo M. The Effectiveness of Myo-Inositol and D-Chiro Inositol Treatment in Type 2 Diabetes. Int J Endocrinol 2016;2016:9132052.

279. Unfer V, Nestler J, Kamenov Z, et al. Effects of Inositol(s) in Women with PCOS: A Systematic Review of Randomized Controlled Trials. Int J Endocrinol 2016;2016:1849162.

280. Genazzani A. Inositol as putative integrative treatment for PCOS. Reprod Biomed Online 2016;33:770–80.

281. Li L, Yang X. The Essential Element Manganese, Oxidative Stress, and Metabolic Diseases: Links and Interactions. Oxid Med Cell Longev 2018;2018:7580707.

282. Shan Z, Chen S, Sun T, et al. U-Shaped Association between Plasma Manganese Levels and Type 2 Diabetes. Environ Health Perspect 2016;124:1876–81.

283. Burlet E, Jain S. Manganese supplementation increases adiponectin and lowers ICAM-1 and creatinine blood levels in Zucker type 2 diabetic rats, and downregulates ICAM-1 by upregulating adiponectin multimerization protein (DsbA-L) in endothelial cells. Mol Cell Biochem 2017;429:1–10.

284. Burlet E, Jain S. Manganese supplementation reduces high glucose-induced monocyte adhesion to endothelial cells and endothelial dysfunction in Zucker diabetic fatty rats. J Biol Chem 2013;288:6409–16.

285. Eckel R, Hanson A, Chen A, et al. Dietary substitution of medium-chain triglycerides improves insulin-mediated glucose metabolism in NIDDM subjects. Diabetes 1992;41:641–7.

286. Yost T, Erskine J, Gregg T, et al. Dietary substitution of medium chain triglycerides in subjects with non-insulin-dependent diabetes mellitus in an ambulatory setting: impact on glycemic control and insulin-mediated glucose metabolism. J Am Coll Nutr 1994;13:615–22.

287. Han J, Deng B, Sun J, et al. Effects of dietary medium-chain triglyceride on weight loss and insulin sensitivity in a group of moderately overweight free-living type 2 diabetic Chinese subjects. Metabolism 2007;56:985–91.

288. Aldawsari H, Hanafy A, Labib G, Badr J. Antihyperglycemic activities of extracts of the mistletoes Plicosepalus acaciae and P. curviflorus in comparison to their solid lipid nanoparticle suspension formulations. Z Naturforsch C 2014;69:391–8.

289. Abdallah H, Farag M, Abdel-Naim A, et al. Mechanistic Evidence of Viscum schimperi (Viscaceae) Antihyperglycemic Activity: From a Bioactivity-guided Approach to Comprehensive Metabolite Profiling. Phytother Res 2015;29:1737–43.

290. Ko B, Kang S, Moon B, et al. A 70% Ethanol Extract of Mistletoe Rich in Betulin, Betulinic Acid, and Oleanolic Acid Potentiated beta-Cell Function and Mass and Enhanced Hepatic Insulin Sensitivity. Evid Based Complement Alternat Med 2016;2016:7836823.

291. Tang Y, Choi E, Han W, et al. Moringa oleifera from Cambodia Ameliorates Oxidative Stress, Hyperglycemia, and Kidney Dysfunction in Type 2 Diabetic Mice. J Med Food 2017;20:502–10.

292. Waterman C, Rojas-Silva P, Tumer T, et al. Isothiocyanate-rich Moringa oleifera extract reduces weight gain, insulin resistance, and hepatic gluconeogenesis in mice. Mol Nutr Food Res 2015;59:1013–24.

293. Azad S, Ansari P, Azam S, et al. Anti-hyperglycaemic activity of Moringa oleifera is partly mediated by carbohydrase inhibition and glucose-fibre binding. Biosci Rep 2017;37.

294. Khan W, Parveen R, Chester K, et al. Hypoglycemic Potential of Aqueous Extract of Moringa oleifera Leaf and In Vivo GC-MS Metabolomics. Front Pharmacol 2017;8:577.

295. Anthanont P, Lumlerdkij N, Akarasereenont P, et al. Moringa Oleifera Leaf Increases Insulin Secretion after Single Dose Administration: A Preliminary Study in Healthy Subjects. J Med Assoc Thai 2016;99:308–13.

296. Taweerutchana R, Lumlerdkij N, Vannasaeng S, et al. Effect of Moringa oleifera Leaf Capsules on Glycemic Control in Therapy-Naive Type 2 Diabetes Patients: A Randomized Placebo Controlled Study. Evid Based Complement Alternat Med 2017;2017:6581390.

297. Wainstein J, Ganz T, Boaz M, et al. Olive leaf extract as a hypoglycemic agent in both human diabetic subjects and in rats. J Med Food 2012;15:605–10.

298. Florentin M, Liberopoulos E, Elisaf M, Tsimihodimos V. No effect of fenugreek, bergamot and olive leaf extract on glucose homeostasis in patients with prediabetes: a randomized double-blind placebo-controlled study. Arch Med Sci Atheroscler Dis 2019;4:e162-e166.

299. Araki R, Fujie K, Yuine N, et al. Olive leaf tea is beneficial for lipid metabolism in adults with prediabetes: an exploratory randomized controlled trial. Nutr Res 2019;67:60–6.

300. de Bock M, Derraik J, Brennan C, et al. Olive (Olea europaea L.) leaf polyphenols improve insulin sensitivity in middle-aged overweight men: a randomized, placebo-controlled, crossover trial. PLoS One 2013;8:e57622.

301. Yao Z, Gu Y, Zhang Q, et al. Estimated daily quercetin intake and association with the prevalence of type 2 diabetes mellitus in Chinese adults. Eur J Nutr 2019;58:819–30.

302. Chen S, Jiang H, Wu X, Fang J. Therapeutic Effects of Quercetin on Inflammation, Obesity, and Type 2 Diabetes. Mediators Inflamm 2016;2016:9340637.

303. Peng J, Li Q, Li K, et al. Quercetin Improves Glucose and Lipid Metabolism of Diabetic Rats: Involvement of Akt Signaling and SIRT1. J Diabetes Res 2017;2017:3417306.

304. Gaballah H, Zakaria S, Mwafy S, et al. Mechanistic insights into the effects of quercetin and/or GLP-1 analogue liraglutide on high-fat diet/streptozotocin-induced type 2 diabetes in rats. Biomed Pharmacother 2017;92:331–9.

305. Valensi P, Le Devehat C, Richard J, et al. A multicenter, double-blind, safety study of QR-333 for the treatment of symptomatic diabetic peripheral neuropathy. A preliminary report. J Diabetes Complications 2005;19:247–53.

306. Yang Z, Wu F, He Y, et al. A novel PTP1B inhibitor extracted from Ganoderma lucidum ameliorates insulin resistance by regulating IRS1-GLUT4 cascades in the insulin signaling pathway. Food Funct 2018;9:397–406.

307. Yang Z, Chen C, Zhao J, et al. Hypoglycemic mechanism of a novel proteoglycan, extracted from Ganoderma lucidum, in hepatocytes. Eur J Pharmacol 2018;820:77–85.

308. Xiao C, Wu Q, Xie Y, et al. Hypoglycemic mechanisms of Ganoderma lucidum polysaccharides F31 in db/db mice via RNA-seq and iTRAQ. Food Funct 2018;9:6495–507.

309. Wang F, Zhou Z, Ren X, et al. Effect of Ganoderma lucidum spores intervention on glucose and lipid metabolism gene expression profiles in type 2 diabetic rats. Lipids Health Dis 2015;14:49.

310. Klupp N, Kiat H, Bensoussan A, et al. A double-blind, randomised, placebo-controlled trial of Ganoderma lucidum for the treatment of cardiovascular risk factors of metabolic syndrome. Sci Rep 2016;6:29540.

311. Ribeiro R, Bonfleur M, Batista T, et al. Regulation of glucose and lipid metabolism by the pancreatic and extra-pancreatic actions of taurine. Amino Acids 2018;50:1511–24.

312. Sak D, Erdenen F, Muderrisoglu C, et al. The Relationship between Plasma Taurine Levels and Diabetic Complications in Patients with Type 2 Diabetes Mellitus. Biomolecules 2019;9.

313. Sarkar P, Basak P, Ghosh S, et al. Prophylactic role of taurine and its derivatives against diabetes mellitus and its related complications. Food Chem Toxicol 2017;110:109–21.

314. Zheng Y, Ceglarek U, Huang T, et al. Plasma Taurine, Diabetes Genetic Predisposition, and Changes of Insulin Sensitivity in Response to Weight-Loss Diets. J Clin Endocrinol Metab 2016;101:3820–6.

315. Cohen N, Halberstam M, Shlimovich P, et al. Oral vanadyl sulfate improves hepatic and peripheral insulin sensitivity in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 1995;95:2501–9.

316. Boden G, Chen X, Ruiz J, et al. Effects of vanadyl sulfate on carbohydrate and lipid metabolism in patients with non-insulin dependent diabetes mellitus. Metabolism 1996;45:1130–5.

317. Cusi K, Cukier S, DeFronzo R, et al. Vanadyl sulfate improves hepatic and muscle insulin sensitivity in type 2 diabetes. J Clin Endocrinol Metab 2001;86:1410–7.

318. Halberstam M, Cohen N, Schlimovich P, et al. Oral vanadyl sulfate improves insulin sensitivity in NIDDM but not in obese nondiabetic subjects. Diabetes 1996;45:659–66.

319. Goldfine A, Patti M, Zuberi L, et al. Metabolic effects of vanadyl sulfate in humans with non-insulin-dependent diabetes mellitus: in vivo and in vitro studies. Metabolism 2000;49:400–10.

320. Thompson K, Lichter J, LeBel C, et al. Vanadium treatment of type 2 diabetes: a view to the future. J Inorg Biochem 2009;103:554–8.

321. Linder K, Willmann C, Kantartzis K, et al. Dietary Niacin Intake Predicts the Decrease of Liver Fat Content During a Lifestyle Intervention. Sci Rep 2019;9:1303.

322. Collins P, Sattar N. Glycaemic Effects of Non-statin Lipid-Lowering Therapies. Curr Cardiol Rep 2016;18:133.

323. Fangmann D, Theismann E, Turk K, et al. Targeted Microbiome Intervention by Microencapsulated Delayed-Release Niacin Beneficially Affects Insulin Sensitivity in Humans. Diabetes Care 2018;41:398–405.

324. Klein G, Stefanuto A, Boaventura B, et al. Mate tea (Ilex paraguariensis) improves glycemic and lipid profiles of type 2 diabetes and pre-diabetes individuals: a pilot study. J Am Coll Nutr 2011;30:320–32.

325. Chen C, Liu J, Sun M, et al. Acupuncture for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials. Complement Ther Clin Pract 2019;36:100–12.

326. Firouzjaei A, Li G, Wang N, et al. Comparative evaluation of the therapeutic effect of metformin monotherapy with metformin and acupuncture combined therapy on weight loss and insulin sensitivity in diabetic patients. Nutr Diabetes 2016;6:e209.

327. Ahn A, Bennani T, Freeman R, et al. Two styles of acupuncture for treating painful diabetic neuropathy—a pilot randomised control trial. Acupunct Med 2007;25:11–7.

328. Bailey A, Wingard D, Allison M, et al. Acupuncture Treatment of Diabetic Peripheral Neuropathy in an American Indian Community. J Acupunct Meridian Stud 2017;10:90–5.

329. Davison K, Temple N. Cereal fiber, fruit fiber, and type 2 diabetes: Explaining the paradox. J Diabetes Complications 2018;32:240–5.

330. Wang Y, Duan Y, Zhu L, et al. Whole grain and cereal fiber intake and the risk of type 2 diabetes: a meta-analysis. Int J Mol Epidemiol Genet 2019;10:38–46.

331. McRae M. Dietary Fiber Intake and Type 2 Diabetes Mellitus: An Umbrella Review of Meta-analyses. J Chiropr Med 2018;17:44–53.

332. Li X, Cai X, Ma X, et al. Short- and Long-Term Effects of Wholegrain Oat Intake on Weight Management and Glucolipid Metabolism in Overweight Type-2 Diabetics: A Randomized Control Trial. Nutrients 2016;8.

333. Jung C, Choi K. Impact of High-Carbohydrate Diet on Metabolic Parameters in Patients with Type 2 Diabetes. Nutrients 2017;9.

334. Ajala O, English P, Pinkney J. Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes. Am J Clin Nutr 2013;97:505–16.

335. Tosti V, Bertozzi B, Fontana L. Health Benefits of the Mediterranean Diet: Metabolic and Molecular Mechanisms. J Gerontol A Biol Sci Med Sci 2018;73:318–26.

336. Guasch-Ferre M, Merino J, Sun Q, et al. Dietary Polyphenols, Mediterranean Diet, Prediabetes, and Type 2 Diabetes: A Narrative Review of the Evidence. Oxid Med Cell Longev 2017;2017:6723931.

337. Esposito K, Maiorino M, Bellastella G, et al A journey into a Mediterranean diet and type 2 diabetes: a systematic review with meta-analyses. BMJ Open 2015;5:e008222.

338. Billingsley H, Carbone S. The antioxidant potential of the Mediterranean diet in patients at high cardiovascular risk: an in-depth review of the PREDIMED. Nutr Diabetes 2018;8:13.

339. Evert A, Dennison M, Gardner C, et al. Nutrition Therapy for Adults with Diabetes or Prediabetes: A Consensus Report. Diabetes Care 2019;42:731–54.

340. Powers M, Bardsley J, Cypress M, et al. Diabetes Self-management Education and Support in Type 2 Diabetes: A Joint Position Statement of the American Diabetes Association, the American Association of Diabetes Educators, and the Academy of Nutrition and Dietetics. Clin Diabetes 2016;34:70–80.

341. Namazi N, Brett N, Bellissimo N, et al. The association between types of seafood intake and the risk of type 2 diabetes: a systematic review and meta-analysis of prospective cohort studies. Health Promot Perspect 2019;9:164–73.

342. Sarmento R, Antonio J, de Miranda I, et al. Eating Patterns and Health Outcomes in Patients With Type 2 Diabetes. J Endocr Soc 2018;2:42–52.

343. Wallin A, Orsini N, Forouhi N, Wolk A. Fish consumption in relation to myocardial infarction, stroke and mortality among women and men with type 2 diabetes: A prospective cohort study. Clin Nutr 2018;37:590–6.

344. Chua J, Chia A, Chee M, et al. The relationship of dietary fish intake to diabetic retinopathy and retinal vascular caliber in patients with type 2 diabetes. Sci Rep 2018;8:730.

345. Kim H, Park S, Yang H, et al. Association between fish and shellfish, and omega-3 PUFAs intake and CVD risk factors in middle-aged female patients with type 2 diabetes. Nutr Res Pract 2015;9:496–502.

346. Kondo K, Morino K, Nishio Y, et al. A fish-based diet intervention improves endothelial function in postmenopausal women with type 2 diabetes mellitus: a randomized crossover trial. Metabolism 2014;63:930–40.

347. Alkhatib A, Tsang C, Tuomilehto J. Olive Oil Nutraceuticals in the Prevention and Management of Diabetes: From Molecules to Lifestyle. Int J Mol Sci 2018;19.

348. Schwingshackl L, Lampousi A, Portillo M, et al. Olive oil in the prevention and management of type 2 diabetes mellitus: a systematic review and meta-analysis of cohort studies and intervention trials. Nutr Diabetes 2017;7:e262.

349. Foscolou A, Critselis E, Panagiotakos D. Olive oil consumption and human health: A narrative review. Maturitas 2018;118:60–6.

350. Yubero-Serrano E, Lopez-Moreno J, Gomez-Delgado F, Lopez-Miranda J. Extra virgin olive oil: More than a healthy fat. Eur J Clin Nutr 2019;72:8–17.

351. Visioli F, Franco M, Toledo E, et al. Olive oil and prevention of chronic diseases: Summary of an International conference. Nutr Metab Cardiovasc Dis 2018;28:649–56.

352. Evert A, Dennison M, Gardner C, et al. Nutrition Therapy for Adults with Diabetes or Prediabetes: A Consensus Report. Diabetes Care 2019;42:731–54.

353. Added Sugars. American Heart Association [updated 2018 Apr 17]. Available from URL: https://www.heart.org/en/healthy-living/healthy-eating/eat-smart/sugar/added-sugars.

354. Remschmidt C, Wichmann O, Harder T. Vaccines for the prevention of seasonal influenza in patients with diabetes: systematic review and meta-analysis. BMC Med 2015;13:53.

355. van Werkhoven C, Huijts S. Vaccines to Prevent Pneumococcal Community-Acquired Pneumonia. Clin Chest Med 2018;39:733–52.

356. Meex R, Blaak E, van Loon L. Lipotoxicity plays a key role in the development of both insulin resistance and muscle atrophy in patients with type 2 diabetes. Obes Rev 2019;20:1205–17.

357. Longo M, Zatterale F, Naderi J, et al. Adipose Tissue Dysfunction as Determinant of Obesity-Associated Metabolic Complications. Int J Mol Sci 2019;20.

358. Grams J, Garvey W. Weight Loss and the Prevention and Treatment of Type 2 Diabetes Using Lifestyle Therapy, Pharmacotherapy, and Bariatric Surgery: Mechanisms of Action. Curr Obes Rep 2015;4:287–302.

359. Luan X, Tian X, Zhang H, et al. Exercise as a prescription for patients with various diseases. J Sport Health Sci 2019;8:422–41.

360. Turner G, Quigg S, Davoren P, et al. Resources to Guide Exercise Specialists Managing Adults with Diabetes. Sports Med Open 2019;5:20.

361. Delevatti R, Bracht C, Lisboa S, et al. The Role of Aerobic Training Variables Progression on Glycemic Control of Patients with Type 2 Diabetes: a Systematic Review with Meta-analysis. Sports Med Open 2019;5:22.

362. Bailey D, Hewson D, Champion R, Sayegh S. Sitting Time and Risk of Cardiovascular Disease and Diabetes: A Systematic Review and Meta-Analysis. Am J Prev Med 2019;57:408–16.

363. Loh R, Stamatakis E, Folkerts D, et al. Effects of Interrupting Prolonged Sitting with Physical Activity Breaks on Blood Glucose, Insulin and Triacylglycerol Measures: A Systematic Review and Meta-analysis. Sports Med 2019.

364. Li X, Yu F, Zhou Y, He J. Association between alcohol consumption and the risk of incident type 2 diabetes: a systematic review and dose-response meta-analysis. Am J Clin Nutr 2016;103:818–29.

365. Knott C, Bell S, Britton A. Alcohol Consumption and the Risk of Type 2 Diabetes: A Systematic Review and Dose-Response Meta-analysis of More Than 1.9 Million Individuals From 38 Observational Studies. Diabetes Care 2015;38:1804–12.

366. Hirst J, Aronson J, Feakins B, et al. Short- and medium-term effects of light to moderate alcohol intake on glycaemic control in diabetes mellitus: a systematic review and meta-analysis of randomized trials. Diabet Med 2017;34:604–11.

367. Gepner Y, Golan R, Harman-Boehm I, et al. Effects of Initiating Moderate Alcohol Intake on Cardiometabolic Risk in Adults With Type 2 Diabetes: A 2-Year Randomized, Controlled Trial. Ann Intern Med 2015;163:569–79.

368. Golan R, Shai I, Gepner Y, et al. Effect of wine on carotid atherosclerosis in type 2 diabetes: a 2-year randomized controlled trial. Eur J Clin Nutr 2018;72:871–8.

369. O'Keefe E, DiNicolantonio J, O'Keefe J, Lavie C. Alcohol and CV Health: Jekyll and Hyde J-Curves. Prog Cardiovasc Dis 2018;61:68–75.

370. Tourkmani A, Alharbi T, Rsheed A, et al. Hypoglycemia in Type 2 Diabetes Mellitus patients: A review article. Diabetes Metab Syndr 2018;12:791–4.

371. Ahren B. Avoiding hypoglycemia: a key to success for glucose-lowering therapy in type 2 diabetes. Vasc Health Risk Manag 2013;9:155–63.

372. Zhu P, Pan X, Sheng L, et al. Cigarette Smoking, Diabetes, and Diabetes Complications: Call for Urgent Action. Curr Diab Rep 2017;17:78.

373. Sliwinska-Mosson M, Milnerowicz H. The impact of smoking on the development of diabetes and its complications. Diab Vasc Dis Res 2017;14:265–76.

374. Worku D, Worku E. A narrative review evaluating the safety and efficacy of e-cigarettes as a newly marketed smoking cessation tool. SAGE Open Med 2019;7:2050312119871405.

375. Machry R, Rados D, Gregorio G, Rodrigues T. Self-monitoring blood glucose improves glycemic control in type 2 diabetes without intensive treatment: A systematic review and meta-analysis. Diabetes Res Clin Pract 2018;142:173–87.

376. Malanda U, Welschen L, Riphagen I, et al. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. Cochrane Database Syst Rev 2012;1:Cd005060.

377. Wood A, O'Neal D, Furler J, Ekinci E. Continuous glucose monitoring: a review of the evidence, opportunities for future use and ongoing challenges. Intern Med J 2018;48:499–508.

378. Carlson A, Mullen D, Bergenstal R. Clinical Use of Continuous Glucose Monitoring in Adults with Type 2 Diabetes. Diabetes Technol Ther 2017;19:S4–11.

Copyright © 2024 TraceGains, Inc. All rights reserved.

Learn more about TraceGains, the company.

The information presented by TraceGains is for informational purposes only. It is based on scientific studies (human, animal, or in vitro), clinical experience, or traditional usage as cited in each article. The results reported may not necessarily occur in all individuals. Self-treatment is not recommended for life-threatening conditions that require medical treatment under a doctor's care. For many of the conditions discussed, treatment with prescription or over the counter medication is also available. Consult your doctor, practitioner, and/or pharmacist for any health problem and before using any supplements or before making any changes in prescribed medications. Information expires December 2024.

Log In

You need to log into the site to use this feature

Create A Free Account To Use Medicine Chest

This feature requires registration. Sign up or log in to your free WellRx account to gain access to this and other tools to help make managing your medications and wellness easier.

Benefits Include:

Store & manage your medication list
Medication pricing updates
Import medication from your pharmacy
Medication information
Pill & refill reminders
Medication journal & mood log

Sign up to use Medicine Chest

Create A Free Account To Use this feature

This feature requires registration. Sign up or log in to your free WellRx account to gain access to this and other tools to help make managing your medications and wellness easier.

Benefits Include:

Store & manage your medication list
Medication pricing updates
Import medication from your pharmacy
Medication information
Pill & refill reminders
Medication journal & mood log

Sign up to use this feature

You will be redirected to your program in 5 seconds.

Hi there.

Our Terms and Conditions and Privacy Policy have recently been updated.

Learn More


I Accept

By declining you will be logged out of your account

;